Lichen planus

L12_LICHENPLANUS

lichen planus: A lichen disease that is located_in skin, located_in tongue or located_in oral mucosa, which presents itself in the form of papules, lesions or rashes. The cause is not known.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L43 Hospital discharge: ICD-9 — 6970A Hospital discharge: ICD-8 — 6970 Cause of death: ICD-10 — L43 Cause of death: ICD-9 — 6970A Cause of death: ICD-8 — 6970 2 out of 7 registries used, show all original rules.	5376
4. Check minimum number of events None	5376
5. Include endpoints None	5376
6. Filter based on genotype QC (FinnGen only)	5210

Control definitions (FinnGen only)

Control exclude: L12_PAPULOSQUAMOUS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L40-L45
Name in latin: Lichen planus

NAME	L12_LICHENPLANUS
CONTROL_EXCLUDE	L12_PAPULOSQUAMOUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L43
HD_ICD_9	6970A
HD_ICD_8	6970
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L43
COD_ICD_9	6970A
COD_ICD_8	6970
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lichen planus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5210	3489	1721
Unadjusted period prevalence (%)	1.09	1.24	0.79
Median age at first event (years)	58.95	59.46	57.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5376: Matched controls
53760

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D07AC13

ATC

mometasone; topical

3.3

307.7

2361

10241

N77.8*L43.9

ICD-10 Finland

Vulvovaginal ulceration and inflammation caused by lichen ruber planus

145.3

307.7

196

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

5.2

307.7

1171

2751

D07AD01

ATC

clobetasol; topical

8.3

307.7

2588

5380

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

25.9

307.7

679

298

L43.8

ICD-10 Finland

Other lichen planus

715.6

307.7

2723

L43.9

ICD-10 Finland

Lichen planus, unspecified

324.6

307.7

2485

142

L43

ICD-10 Finland

Lichen planus

40.8

307.7

619

171

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

7.3

307.7

502

744

L43.3

ICD-10 Finland

Subacute (active) lichen planus

264.4

307.7

276

E0000UV, ,

ATC

3.1

307.7

3031

15988

D07AC01

ATC

betamethasone; topical

5.1

307.7

3397

13476

EKA10

NOMESCO Finland

iopsy of buccal mucosa

16.3

307.7

664

461

D05BB02

ATC

acitretin; oral

22.5

307.7

366

174

L43.0

ICD-10 Finland

Hypertrophic lichen planus

655.4

307.7

784

SBA00

NOMESCO Finland

Microbiological examinations

7.8

300.7

433

595

L40.0

ICD-10 Finland

Psoriasis vulgaris

16.4

294.1

251

160

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.1

289.0

1645

6704

ECA20

NOMESCO Finland

Biopsy of gingiva

13.5

273.7

261

203

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

7.3

270.1

412

603

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

7.9

247.3

350

470

D07AB02

ATC

hydrocortisone butyrate; topical

2.6

243.3

2121

10648

A01AC01

ATC

triamcinolone; local oral

8.8

240.2

308

367

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

14.4

219.9

201

145

K13.29

ICD-10 Finland

Indefinite leukoplakia

10.9

212.6

232

222

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

5.7

187.2

360

663

E000001, ,

ATC

2.6

180.5

1353

6169

L43.1

ICD-10 Finland

Bullous lichen planus

908.3

180.3

176

A07AA02

ATC

nystatin; oral

3.7

170.5

600

1779

ULA02

NOMESCO Finland

Kolposcopy

3.1

150.4

699

2458

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

149.4

2346

14410

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.1

148.3

440

1155

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

46.5

148.2

TQW80

NOMESCO Finland

Local dermatologic skincare

5.6

145.1

282

523

D09AB01

ATC

zinc bandage without supplements; topical

6.6

145.0

238

374

K13.20

ICD-10 Finland

Idiopathic leukoplakia

16.8

140.1

117

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

139.1

1811

10295

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

4.1

132.6

380

971

XQ802

NOMESCO Finland

Epicutan test

4.2

129.9

365

919

L28.0

ICD-10 Finland

Lichen simplex chronicus

9.2

128.8

158

177

XQ848

NOMESCO Finland

Dermatological photography

4.8

126.1

293

635

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.9

125.9

686

2624

D05AX52

ATC

calcipotriol, combinations; topical

4.6

125.8

313

717

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.1

119.0

1498

8318

D07AB08

ATC

desonide; topical

2.7

117.7

742

3054

LEB00

NOMESCO Finland

Biopsy of vagina

5.6

114.7

221

406

69700

ICD-8 Finland

Lichen, Planus

+∞

113.9

109

H02AB06

ATC

prednisolone; systemic

1.9

112.0

2832

19877

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

16.6

104.6

L43.2

ICD-10 Finland

Lichenoid drug reaction

262.9

101.1

103

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.4

100.3

390

1222

L40.5

ICD-10 Finland

Arthropathic psoriasis

34.8

98.1

K13.78

ICD-10 Finland

Other change in the oral mucosa

4.4

97.0

251

592

B37.08

ICD-10 Finland

Other candidal stomatitis

7.9

96.1

132

170

SXA10

NOMESCO Finland

Oral mucosal sampling

6.4

94.4

159

256

J02AC01

ATC

fluconazole; systemic

1.8

90.8

2337

16135

A01AB09

ATC

miconazole; local oral

2.5

89.1

634

2746

D07XC01

ATC

betamethasone; topical

2.4

85.3

688

3150

SAA04

NOMESCO Finland

Special examination of mouth

3.1

83.6

378

1294

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

82.5

2062

14004

EJ2S1

NOMESCO Finland

Photography of oral mucosa

8.2

79.0

105

130

E000002, ,

ATC

2.3

78.0

642

2960

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

6.8

77.5

122

183

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

17.6

74.8

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

8.7

73.6

108

N89.5

ICD-10 Finland

Stricture and atresia of vagina

22.3

72.1

D07BC01

ATC

betamethasone and antiseptics; topical

2.1

71.8

745

3767

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

71.1

3780

31014

L40.8

ICD-10 Finland

Other psoriasis

21.9

70.2

D02AE01

ATC

carbamide; topical

2.6

67.9

413

1653

E000006, ,

ATC

2.5

66.3

468

2009

R06AE07

ATC

cetirizine; oral

1.6

65.4

2413

17856

D05AX02

ATC

calcipotriol; topical

4.2

64.8

178

439

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.0

64.4

757

4000

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

18.4

63.8

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

61.0

3411

27740

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.8

58.9

320

1208

A01AB04

ATC

amphotericin B; local oral

2.6

58.5

346

1364

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

10.0

57.8

TEA00

NOMESCO Finland

Biopsy of lip

5.7

56.6

105

186

L04AX03

ATC

methotrexate; systemic

2.2

56.3

535

2601

R06AX27

ATC

desloratadine; oral

1.7

56.3

1484

9996

R01AD11

ATC

triamcinolone; nasal

2.2

55.8

541

2651

6970A

ICD-9 Finland

Lichen planus[LICHEN RUBER PLANUS]

+∞

55.3

K12.10

ICD-10 Finland

Stomatitis NOS

8.3

54.7

XQ845

NOMESCO Finland

Dermatoscopy

4.0

52.9

153

392

J01DB01

ATC

cefalexin; oral

1.7

52.1

4365

38379

E000007, ,

ATC

2.6

50.6

317

1284

L40.9

ICD-10 Finland

Psoriasis, unspecified

8.2

49.1

S29

ICPC

Skin symptom/complaint other

1.7

46.7

1070

6895

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

46.7

2850

22977

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

45.7

1605

11476

D07AC14

ATC

methylprednisolone aceponate; topical

2.5

44.9

285

1161

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

44.7

697

4018

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

43.9

2142

16413

SFA10

NOMESCO Finland

One-surface restoration

1.5

43.1

2765

22369

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.9

42.5

607

3401

L30.8

ICD-10 Finland

Other specified dermatitis

3.1

41.4

174

569

N02BE01

ATC

paracetamol; systemic, rectal

1.8

41.3

4773

43708

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.8

41.3

200

L66.1

ICD-10 Finland

Lichen planopilaris

16.0

40.9

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

15.1

40.8

R06AE09

ATC

levocetirizine; oral

1.8

40.7

750

4535

K12.18

ICD-10 Finland

Other forms of stomatitis

5.7

40.4

133

S18

ICPC

Laceration/cut

1.5

40.3

2419

19216

EHA10

NOMESCO Finland

Biopsy of palate

5.8

39.7

125

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.8

39.6

679

4019

R01AD09

ATC

mometasone; nasal

1.5

39.0

2300

18167

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

38.9

489

2622

UJF32

NOMESCO Finland

Coloscopy

1.5

38.7

1435

10315

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

37.9

1460

10570

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

37.8

2347

18686

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

37.7

1344

9569

D07AA02

ATC

hydrocortisone; topical

1.8

37.5

673

4033

J02AC02

ATC

itraconazole; systemic

1.6

37.5

980

6492

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

37.2

3590

31015

A02BC05

ATC

esomeprazole; systemic

1.5

37.0

2189

17244

SFA20

NOMESCO Finland

Two-surface restoration

1.4

37.0

2894

24018

N05BB01

ATC

hydroxyzine; systemic

2.2

36.9

343

1646

XQ800

NOMESCO Finland

Prick test

2.1

36.2

378

1896

R03AC02

ATC

salbutamol; inhalant

1.4

36.0

2786

23027

M79.6

ICD-10 Finland

Pain in limb

1.4

35.7

2176

17207

SDA03

NOMESCO Finland

Periodontal treatment

1.5

35.4

1990

15493

J01DA01

ATC

[U] cefalexin

1.4

35.2

3145

26634

Z01.2

ICD-10 Finland

Dental examination

1.4

34.8

2233

17795

P01AB01

ATC

metronidazole; oral, rectal

1.4

34.8

2072

16287

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

8.4

34.7

A07EA02

ATC

hydrocortisone; rectal

3.2

34.6

137

433

A02BC03

ATC

lansoprazole; oral

1.5

34.5

1549

11534

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

34.4

2239

17881

K02.1

ICD-10 Finland

Caries of dentine

1.4

33.9

2824

23544

L40

ICD-10 Finland

Psoriasis

4.6

33.8

172

P01BA02

ATC

hydroxychloroquine; oral

1.9

33.4

481

2694

D02AX

ATC

Other emollients and protectives

2.8

33.2

168

610

EJB10

NOMESCO Finland

Excision of tumor or other lesion of apex or body of tongue

6.1

33.1

J01AA02

ATC

doxycycline; systemic

1.5

32.9

4120

36911

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.9

32.8

159

564

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

7.4

32.6

M25.5

ICD-10 Finland

Pain in joint

1.5

32.3

1634

12414

SPAT1263

SPAT

Sampling

1.4

32.3

2092

16632

N02AX02

ATC

tramadol; systemic, rectal

1.4

32.3

2217

17809

D05AX03

ATC

calcitriol; topical

6.3

32.1

A02BC02

ATC

pantoprazole; systemic

1.4

32.1

3611

31602

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

4.3

32.0

192

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

32.0

2377

19347

N77.8

ICD-10 Finland

Vulvovaginal ulceration and inflammation in other diseases classified elsewhere

43.6

31.8

R01AD08

ATC

fluticasone; nasal

1.5

31.8

1428

10599

B37.01

ICD-10 Finland

Acute athrophy candidal stomatitis

9.3

31.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

31.7

1178

8412

J01CA04

ATC

amoxicillin; systemic

1.5

31.7

4149

37312

K12.00

ICD-10 Finland

Recurrent oral aphthae

3.8

31.5

260

L30.0

ICD-10 Finland

Nummular dermatitis

2.4

31.5

215

905

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

31.0

1742

13472

N48.1

ICD-10 Finland

Balanoposthitis

3.2

30.6

125

403

SPAT1301

SPAT

No procedures

1.4

30.5

1579

12022

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

30.5

1145

8186

J01FF01

ATC

clindamycin; systemic

1.5

29.6

1359

10106

H03AA01

ATC

levothyroxine sodium; systemic

1.5

29.5

1293

9528

L28.1

ICD-10 Finland

Prurigo nodularis

4.6

29.4

151

L29.2

ICD-10 Finland

Pruritus vulvae

3.4

29.1

106

318

L17

ICPC

Foot/toe symptom/complaint

1.4

29.0

1474

11162

EBA00

NOMESCO Finland

Extraction of tooth

1.4

28.8

1669

12941

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

28.8

164

634

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

28.5

430

2441

S21

ICPC

Skin texture symptom/complaint

1.6

28.3

729

4785

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

28.3

654

4180

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

28.3

267

1289

LFA00

NOMESCO Finland

Incision of vulva or perineum

10.1

28.3

SPAT1310

SPAT

Counselling related to known health issue

1.4

28.0

1577

12151

A07EA06

ATC

budesonide; oral, local oral

2.4

28.0

198

848

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

27.8

1469

11191

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

27.8

2091

16928

G01AA10

ATC

clindamycin; vaginal

1.6

27.8

750

4977

SPAT1312

SPAT

General health counselling

1.4

27.7

1521

11662

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

27.7

333

1755

L93.0

ICD-10 Finland

Discoid lupus erythematosus

5.5

27.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

27.3

1765

13916

SXC03

NOMESCO Finland

Other oral or dental procedure

4.0

27.3

190

J01MA02

ATC

ciprofloxacin; systemic

1.4

27.2

1930

15458

M07.3

ICD-10 Finland

Other psoriatic arthropathies

30.2

27.2

M01AH05

ATC

etoricoxib; oral

1.4

27.2

3160

27387

M03BX02

ATC

tizanidine; oral

1.4

26.3

3126

27120

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

26.2

2346

19465

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

5.2

26.2

102

N03AX16

ATC

[U] pregabalin

1.4

26.1

1216

9034

S99

ICPC

Skin disease other

2.9

26.1

126

447

-1, ,

NOMESCO Finland

1.4

25.8

1499

11580

TLE00

NOMESCO Finland

Dilatation of vagina

40.3

25.8

N76.6

ICD-10 Finland

Ulceration of vulva

4.4

25.7

147

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.3

25.6

304

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.6

25.4

154

614

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

4.1

25.3

170

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

25.2

1119

8230

SPAT1153

SPAT

Removal of sutures

1.4

25.2

1640

12909

J01FA10

ATC

azithromycin; systemic

1.4

25.2

2791

23878

R01AD01

ATC

beclometasone; nasal

1.5

24.7

770

5270

KMAK, ,

NOMESCO Finland

1.3

24.6

2425

20351

E000003, ,

ATC

2.2

24.6

200

910

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

24.4

599

3879

L30.3

ICD-10 Finland

Infective dermatitis

2.3

24.3

178

775

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

24.2

1861

15020

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

24.2

538

3397

M01AC06

ATC

meloxicam; systemic, rectal

1.4

24.1

1913

15516

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

23.9

2719

23271

SBB10

NOMESCO Finland

Dental impressions

1.9

23.9

291

1540

N90.4

ICD-10 Finland

Leukoplakia of vulva

5.4

23.8

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

3.0

23.6

102

340

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

23.6

1237

9362

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

23.5

382

2214

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

23.5

469

2880

G47.3

ICD-10 Finland

Sleep apnoea

1.4

23.5

1061

7816

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.7

23.5

129

490

N03AX12

ATC

[U] gabapentin; oral

1.5

23.4

847

5977

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

23.2

1283

9795

R05

ICPC

Cough

1.4

23.1

1167

8772

WX290

NOMESCO Finland

Other blockage of nerve

1.3

22.9

2045

16849

KGH10

NOMESCO Finland

Operation for phimosis

2.9

22.9

107

373

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

22.8

1430

11150

SXC05

NOMESCO Finland

Other oral or dental procedure

1.9

22.7

300

1632

L57.0

ICD-10 Finland

Actinic keratosis

1.6

22.6

555

3590

K13.2

ICD-10 Finland

Leukoplakia and other disturbances of oral epithelium, including tongue

7.5

22.5

D07AC03

ATC

desoximetasone; topical

3.0

22.4

329

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

22.4

1126

8449

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

22.4

281

1503

A02BC01

ATC

omeprazole; systemic

1.4

22.3

1359

10538

SFA00

NOMESCO Finland

Small restoration

1.5

22.3

678

4607

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

22.3

1269

9731

A01AB10

ATC

natamycin; local oral

2.4

22.2

156

666

R13

ICD-10 Finland

Dysphagia

1.8

22.2

360

2084

EMAK, ,

NOMESCO Finland

2.2

22.2

188

870

SPAT1260

SPAT

Consultation of another employee

1.5

22.1

869

6226

S02

ICPC

Pruritus

2.3

22.1

176

794

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.4

22.1

159

687

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

21.9

747

5199

A02BA02

ATC

ranitidine; systemic

1.4

21.9

982

7214

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

+∞

21.9

L40.4

ICD-10 Finland

Guttate psoriasis

38.8

21.7

L04AB04

ATC

adalimumab; parenteral

2.9

21.7

341

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

21.7

869

6249

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

21.5

489

3102

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.8

21.5

317

1784

C05AA08

ATC

fluocortolone; rectal, topical

1.5

21.5

699

4816

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

21.3

2480

21156

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

7.5

21.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

21.1

1030

7678

D07AB01

ATC

clobetasone; topical

2.3

20.9

167

754

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

20.9

147

629

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

20.9

676

4653

A46

ICD-10 Finland

Erysipelas

1.5

20.7

687

4750

D82

ICPC

Teeth/gum disease

1.3

20.6

1659

13404

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

20.5

1189

9125

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

20.5

2055

17141

M54.5

ICD-10 Finland

Low back pain

1.3

20.4

1710

13896

J05AB01

ATC

aciclovir; systemic

1.4

20.3

1065

8034

R01AD12

ATC

fluticasone furoate; nasal

1.4

20.3

1419

11220

D01BA02

ATC

terbinafine; oral

1.4

20.1

1209

9327

K11.70

ICD-10 Finland

Hypoptyalism

4.2

19.9

124

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

19.9

1517

12144

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

19.8

2193

18521

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

19.7

618

4221

N06AX11

ATC

mirtazapine; oral

1.3

19.7

1644

13337

R06.0

ICD-10 Finland

Dyspnoea

1.4

19.6

1309

10263

SFA30

NOMESCO Finland

Three-surface restoration

1.3

19.6

2037

17042

Z70.8

ICD-10 Finland

Other sex counselling

7.1

19.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

19.4

1271

9938

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

6.1

19.4

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

19.3

523

3457

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

19.2

1222

9503

SBA10

NOMESCO Finland

Measurement of salivary flow rate

3.3

19.1

212

S91

ICPC

Psoriasis

6.4

18.8

K13.03

ICD-10 Finland

Keilit UNS

6.4

18.8

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

18.8

691

4876

N76.0

ICD-10 Finland

Acute vaginitis

1.9

18.6

223

1175

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

18.5

338

2025

L50.3

ICD-10 Finland

Dermatographic urticaria

2.8

18.4

339

H02AB04

ATC

methylprednisolone; systemic

1.5

18.2

713

5091

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

18.2

1393

11132

L03

ICPC

Low back symptom/complaint

1.3

18.2

1327

10529

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

3.2

18.1

224

SPAT1325

SPAT

Vaccination

1.3

18.1

1601

13062

K05.30

ICD-10 Finland

Periodontitis complex

1.5

18.1

696

4952

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

17.8

528

3559

L04AX01

ATC

azathioprine; systemic

2.0

17.8

203

1051

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

17.8

674

4780

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

17.8

860

6381

J01FA06

ATC

roxithromycin; oral

1.3

17.8

1951

16382

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

17.7

647

4556

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

17.7

511

3426

M01AH01

ATC

celecoxib; oral

1.4

17.5

911

6842

B35.3

ICD-10 Finland

Tinea pedis

2.0

17.5

201

1044

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

17.4

369

2298

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

17.3

526

3564

R42

ICD-10 Finland

Dizziness and giddiness

1.4

17.3

1124

8752

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

17.3

841

6246

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

17.3

1143

8927

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

17.3

1250

9896

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

17.2

277

1600

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

17.1

753

5490

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

17.0

2009

17002

EKB00

NOMESCO Finland

Excision of tumour or other lesion of cheek

4.6

16.8

N05CF02

ATC

zolpidem; oral

1.4

16.8

840

6267

L15

ICPC

Knee symptom/complaint

1.3

16.7

1190

9390

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

16.7

304

1819

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

16.6

1435

11640

N06AX21

ATC

duloxetine; oral

1.5

16.6

560

3878

R03BA01

ATC

beclometasone; inhalant

1.4

16.6

674

4841

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

16.6

1014

7815

WX720

NOMESCO Finland

Own respiration

1.8

16.5

230

1272

L04AD01

ATC

ciclosporin; systemic

2.7

16.5

319

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.4

16.4

116

498

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

16.4

2076

17705

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

16.3

374

2378

L08

ICPC

Shoulder symptom/complaint

1.4

16.2

1061

8261

UKC02

NOMESCO Finland

Cystoscopy

1.4

16.2

696

5051

M01AB05

ATC

diclofenac; systemic, rectal

1.3

16.1

3294

29749

R03BA05

ATC

fluticasone; inhalant

1.4

16.1

828

6201

G44.2

ICD-10 Finland

Tension-type headache

1.5

16.0

630

4496

R03BA02

ATC

budesonide; inhalant

1.4

15.9

826

6195

R06AX22

ATC

ebastine; oral

1.4

15.8

791

5894

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

15.8

492

3350

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

15.8

959

7376

EAA10

NOMESCO Finland

Excision of lesion of lip

2.9

15.8

254

K30

ICD-10 Finland

Functional dyspepsia

1.5

15.8

530

3666

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

15.8

1026

7976

-, ,

ICD-10 Finland

2.3

15.8

115

501

D19

ICPC

Teeth/gum symptom/complaint

1.3

15.8

1250

10007

L20.0

ICD-10 Finland

Besnier prurigo

1.8

15.7

260

1515

R52.9

ICD-10 Finland

Pain, unspecified

1.5

15.7

456

3059

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

15.7

161

804

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

15.6

315

1938

L41.1

ICD-10 Finland

Pityriasis lichenoides chronica

160.5

15.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

15.5

888

6768

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

15.5

3180

28668

J01EA01

ATC

trimethoprim; systemic

1.3

15.4

1297

10463

A07EC02

ATC

mesalazine; oral, rectal

1.8

15.4

231

1309

K50.8

ICD-10 Finland

Other Crohn disease

2.9

15.3

237

C10AX09

ATC

ezetimibe; oral

1.4

15.3

764

5692

S06

ICPC

Rash localized

1.7

15.2

269

1598

D06BX01

ATC

metronidazole; topical

1.5

15.2

515

3570

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

15.1

945

7301

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

15.0

1813

15320

R03DC03

ATC

montelukast; oral

1.4

14.8

766

5735

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.8

14.8

214

1198

J01FA09

ATC

clarithromycin; systemic

1.3

14.8

1458

12006

D83

ICPC

Mouth/tongue/lip disease

3.7

14.7

121

S01

ICPC

Pain/tenderness of skin

1.8

14.7

223

1267

M48.0

ICD-10 Finland

Spinal stenosis

1.4

14.7

611

4405

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

14.6

167

866

K14.61

ICD-10 Finland

Glossodynia

3.2

14.6

175

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

+∞

14.6

M79.1

ICD-10 Finland

Myalgia

1.4

14.6

640

4658

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

14.6

122

564

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

2.9

14.5

233

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

14.5

938

7280

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

14.5

1128

8994

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

14.4

193

1055

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

14.4

567

4044

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

14.4

4561

43225

M01AE02

ATC

naproxen; oral, rectal

1.3

14.4

2666

23655

K03.00

ICD-10 Finland

Approximal wear

1.6

14.3

300

1863

T78.3

ICD-10 Finland

Angioneurotic oedema

2.8

14.3

246

R05

ICD-10 Finland

Cough

1.3

14.3

1000

7846

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

14.3

160

824

R51.80

ICD-10 Finland

Headache

1.4

14.3

671

4940

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

5.5

14.3

E000004, ,

ATC

2.4

14.3

386

D01AC02

ATC

miconazole; topical

1.6

14.2

339

2173

ZY010

NOMESCO Finland

Hospital outpatient

1.8

14.2

194

1067

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

14.2

193

1061

K07.60

ICD-10 Finland

Snapping jaw

1.8

14.2

220

1259

KGB00

NOMESCO Finland

Biopsy of penis

13.4

14.2

EBB10

NOMESCO Finland

Insertion of dental implant

2.7

14.2

287

M01AX01

ATC

nabumetone; oral

1.8

14.1

213

1208

XKD00

NOMESCO Finland

Uroflowmetry

1.4

14.1

581

4177

D07XB05

ATC

dexamethasone; topical

2.2

14.1

120

558

K03.66

ICD-10 Finland

Tooth plaque

1.6

14.1

331

2116

R01AD58

ATC

fluticasone, combinations; nasal

1.3

14.0

1024

8089

K08.80

ICD-10 Finland

Toothache NOS

1.6

13.9

367

2410

A98

ICPC

Health maint/preventive medicine

1.6

13.9

5088

49258

L44.3

ICD-10 Finland

Lichen ruber moniliformis

30.1

13.9

N06AA09

ATC

amitriptyline; systemic

1.5

13.9

484

3373

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.2

13.8

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

13.8

367

2413

R21

ICPC

Throat symptom/complaint

1.4

13.8

783

5947

H02AB07

ATC

prednisone; oral

1.4

13.7

638

4690

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.5

13.6

328

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

13.6

814

6237

M02AA07

ATC

piroxicam; topical

1.3

13.5

1794

15284

N30.0

ICD-10 Finland

Acute cystitis

1.4

13.5

778

5922

L42

ICD-10 Finland

Pityriasis rosea

4.4

13.5

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

13.5

657

4866

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

13.4

838

6461

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

13.4

670

4985

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

13.4

503

3555

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

13.4

1062

8477

L01

ICPC

Neck symptom/complaint

1.4

13.4

704

5283

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

13.3

234

1387

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

13.3

330

2135

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

13.3

1113

8947

J01DA09

ATC

[U] cefadroxil

1.3

13.3

1182

9579

104

Kela drug reimbursment

Thyroid insufficiency

1.5

13.2

375

2502

ECA30

NOMESCO Finland

Excision of lesion of gingiva

2.9

13.2

202

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

13.1

1926

16585

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

13.0

678

5076

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

13.0

1268

10398

H92.0

ICD-10 Finland

Otalgia

1.7

13.0

253

1543

EB1VA, ,

NOMESCO Finland

1.4

12.9

539

3883

A02BC04

ATC

rabeprazole; oral

1.5

12.9

409

2793

N06AX26

ATC

vortioxetine; oral

1.6

12.9

270

1677

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

12.8

420

2889

L71.8

ICD-10 Finland

Other rosacea

2.4

12.7

357

SGA01

NOMESCO Finland

Emergency treatment

1.4

12.7

644

4799

SPAT1240

SPAT

Therapeutic discussion

1.5

12.7

391

2655

L73.8

ICD-10 Finland

Other specified follicular disorders

3.2

12.7

149

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

12.6

1047

8399

J01AA04

ATC

lymecycline; systemic

1.4

12.6

511

3664

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

12.6

533

3852

N06AX16

ATC

venlafaxine; oral

1.4

12.6

603

4454

L12

ICPC

Hand/finger symptom/complaint

1.4

12.5

710

5387

J05AB11

ATC

valaciclovir; oral

1.4

12.5

671

5048

L44.2

ICD-10 Finland

Lichen striatus

+∞

12.5

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

12.5

385

2615

D11

ICPC

Diarrhoea

1.5

12.5

467

3297

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

12.5

602

4450

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

12.5

602

4450

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

12.5

378

2559

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

12.4

482

3427

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

12.4

1760

15077

J01CA08

ATC

pivmecillinam; oral

1.2

12.3

2035

17719

SPAT1097

SPAT

Recording of ECG

1.4

12.3

692

5242

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

12.3

433

3020

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.1

12.3

162

R06AX13

ATC

loratadine; oral

1.4

12.3

647

4850

J01AA07

ATC

tetracycline; systemic

1.4

12.3

600

4443

R07.0

ICD-10 Finland

Pain in throat

1.6

12.3

267

1676

A03

ICPC

Fever

1.4

12.3

630

4706

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

12.3

485

3461

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

12.2

251

1552

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

12.2

283

1803

EJ2S1, ,

SPAT

10.5

12.2

N76.2

ICD-10 Finland

Acute vulvitis

3.7

12.2

104

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.6

12.2

251

QXA05

NOMESCO Finland

Skin division, unspecified location

4.9

12.1

G04BD12

ATC

mirabegron; oral

1.4

12.1

579

4271

B37.02

ICD-10 Finland

Chronic hyperplastic candidal stomatitis

15.9

12.1

L13

ICPC

Hip symptom/complaint

1.3

12.1

925

7334

R60.0

ICD-10 Finland

Localized oedema

1.4

12.1

572

4213

K05.12

ICD-10 Finland

Gingivitis (chronic) simple marginal

12.4

12.1

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

12.1

314

2055

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

3.9

12.1

R09

ICPC

Sinus symptom/complaint

1.5

12.0

342

2283

VALMI, ,

NOMESCO Finland

1.3

12.0

1002

8038

L04AC10

ATC

secukinumab; parenteral

11.0

12.0

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.5

12.0

357

2407

WX704

NOMESCO Finland

Intubation

1.5

12.0

360

2432

R74

ICPC

Upper respiratory infection acute

1.3

12.0

1244

10265

N05CF01

ATC

zopiclone; oral

1.3

12.0

1539

13024

EDB00

NOMESCO Finland

Partial excision of mandible

8.7

12.0

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

8.7

12.0

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

11.9

320

2109

P03

ICPC

Feeling depressed

1.5

11.9

336

2239

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.1

11.9

116

570

M01AX17

ATC

nimesulide; oral

1.3

11.8

1185

9734

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.9

11.8

193

K13

ICD-10 Finland

Other diseases of lip and oral mucosa

5.4

11.8

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

11.8

562

4145

M45

ICD-10 Finland

Ankylosing spondylitis

2.3

11.8

389

S87

ICPC

Dermatitis/atopic eczema

2.2

11.7

447

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

11.7

177

1006

J04BA02

ATC

dapsone; oral

3.9

11.7

SPAT1058

SPAT

PEF monitoring instruction

1.5

11.7

383

2634

R02

ICPC

Shortness of breath/dyspnoea

1.4

11.7

590

4393

L02

ICPC

Back symptom/complaint

1.5

11.7

423

2968

U02

ICPC

Urinary frequency/urgency

1.4

11.7

679

5172

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

11.6

317

2098

Z71.8

ICD-10 Finland

Other specified counselling

1.3

11.6

1316

10969

L44.1

ICD-10 Finland

Lichen nitidus

65.1

11.6

UDC00

NOMESCO Finland

Ear microscopy

1.5

11.6

325

2164

D01AE15

ATC

terbinafine; topical

1.6

11.6

307

2019

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

5.2

11.5

SCA02

NOMESCO Finland

Preventive oral health care

1.5

11.5

386

2668

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.3

11.5

128

L04AA32

ATC

apremilast; oral

+∞

11.5

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

11.4

396

2754

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

11.4

331

2219

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

11.4

248

1557

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.7

11.4

202

1203

G04CA02

ATC

tamsulosin; oral

1.3

11.3

793

6206

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.4

11.3

455

3255

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.9

11.3

148

805

F29

ICPC

Eye symptom/complaint other

1.5

11.3

415

2919

D07CB01

ATC

triamcinolone and antibiotics; topical

2.2

11.3

428

L29.0

ICD-10 Finland

Pruritus ani

2.9

11.3

176

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

11.3

461

3307

ZXC50

NOMESCO Finland

Cryotherapy

1.9

11.3

149

813

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

11.2

1245

10342

S08

ICPC

Skin colour change

1.6

11.2

259

1650

B86

ICD-10 Finland

Scabies

2.2

11.2

404

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.6

11.2

233

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.8

11.2

174

999

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

11.1

649

4944

B37.0

ICD-10 Finland

Candidal stomatitis

2.7

11.1

217

S76

ICPC

Skin infection other

1.6

11.1

229

1420

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

11.0

340

2311

Z00.0

ICD-10 Finland

General medical examination

1.3

11.0

841

6662

L20.8

ICD-10 Finland

Other atopic dermatitis

2.8

11.0

201

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

11.0

387

2701

H01

ICPC

Ear pain/earache

1.4

11.0

466

3367

L28

ICPC

Limited function/disability (L)

1.3

11.0

835

6611

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

13.9

10.9

N01

ICPC

Headache

1.5

10.9

390

2729

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

10.9

1246

10384

L04AA13

ATC

[U] leflunomide

2.0

10.9

112

562

SAE01, ,

NOMESCO Finland

2.7

10.9

208

H29

ICPC

Ear symptom/complaint other

1.4

10.8

518

3820

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

3.5

10.8

103

ZXA05

NOMESCO Finland

Left side

1.3

10.8

1166

9653

G03CA04

ATC

estriol; systemic, vaginal

1.5

10.7

360

2488

L04AA01

ATC

[U] ciclosporin

2.5

10.7

262

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

3.5

10.7

104

L12.0

ICD-10 Finland

Bullous pemphigoid

3.5

10.7

104

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.0

10.7

106

525

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

10.7

863

6886

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

10.7

301

2007

R03AC03

ATC

terbutaline; inhalant

1.4

10.7

618

4701

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

10.6

443

3190

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

3.1

10.6

140

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

10.6

525

3898

C07AB07

ATC

bisoprolol; oral

1.2

10.5

2353

21023

M01AH02

ATC

rofecoxib; oral

1.4

10.5

608

4622

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.2

10.5

408

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.3

10.5

115

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

10.5

586

4433

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

+∞

10.4

S88

ICPC

Dermatitis contact/allergic

2.1

10.4

437

R96

ICPC

Asthma

1.4

10.4

448

3248

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

10.3

168

977

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

10.3

303

2038

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

10.3

225

1414

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

10.3

319

2169

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

10.3

122

643

A04

ICPC

Weakness/tiredness general

1.3

10.3

619

4734

ZXC10

NOMESCO Finland

Use of laser

2.1

10.3

485

M01AX05

ATC

glucosamine; oral

1.3

10.2

1014

8300

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

23.4

10.2

L28.2

ICD-10 Finland

Other prurigo

4.0

10.2

N02BF01

ATC

gabapentin; oral

1.5

10.2

369

2589

K11.2

ICD-10 Finland

Sialoadenitis

1.8

10.2

151

855

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.1

10.1

133

R30.0

ICD-10 Finland

Dysuria

1.7

10.1

176

1044

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

10.1

308

2089

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

10.1

234

R03BA08

ATC

ciclesonide; inhalant

1.4

10.0

391

2782

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.4

10.0

289

J01MA12

ATC

levofloxacin; systemic

1.3

10.0

810

6462

N06AB10

ATC

escitalopram; oral

1.3

10.0

810

6463

K60.1

ICD-10 Finland

Chronic anal fissure

2.0

10.0

105

532

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

10.0

212

1325

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

1.9

9.9

115

602

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.7

9.9

194

1187

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

9.9

277

1846

L01BA01

ATC

methotrexate; systemic

1.8

9.9

149

849

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

9.8

218

1377

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

3.1

9.8

131

E66.01

ICD-10 Finland

Obesity due to excess calories

1.5

9.7

340

2369

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

9.7

310

2122

N94.1

ICD-10 Finland

Dyspareunia

2.9

9.7

153

M54.2

ICD-10 Finland

Cervicalgia

1.5

9.6

338

2358

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

9.6

295

2003

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

9.6

369

2619

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.6

805

6449

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

9.6

413

2992

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.6

9.6

238

1544

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

9.6

173

1037

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

9.6

513

3855

N89.8

ICD-10 Finland

Other specified noninflammatory disorders of vagina

3.3

9.6

107

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.5

9.5

223

LEA10

NOMESCO Finland

Colpotomy

15.0

9.5

R52.2

ICD-10 Finland

Other chronic pain

1.7

9.5

164

972

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

9.5

125

684

K07.23

ICD-10 Finland

Deep bite

2.3

9.5

322

S02CA02

ATC

flumetasone and antiinfectives; otic

1.6

9.4

235

1525

N81.6

ICD-10 Finland

Rectocele

1.4

9.4

351

2476

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

9.4

224

1439

M79.7

ICD-10 Finland

Fibromyalgia

1.7

9.4

157

921

A11

ICPC

Chest pain NOS

1.4

9.4

370

2638

R4110, ,

SPAT

1.4

9.4

406

2944

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

+∞

9.4

8070/3-C03.1

ICD-O-3

Squamous cell carcinoma, NOS, of lower gum

21.7

9.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

9.3

1143

9578

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.5

9.3

283

1920

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

9.3

299

2052

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

9.3

518

3918

EBB15

NOMESCO Finland

Insertion of dental implant abutment

2.8

9.2

157

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

9.5

9.2

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

9.2

905

7389

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.9

9.2

109

576

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

3.2

9.2

110

G50.1

ICD-10 Finland

Atypical facial pain

2.1

9.1

412

L29.8

ICD-10 Finland

Other pruritus

2.3

9.1

270

U07

ICPC

Urine symptom/complaint other

1.5

9.1

332

2332

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.6

9.1

213

1362

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

9.1

231

1507

K12

ICD-10 Finland

Stomatitis and related lesions

5.0

9.1

K04.08

ICD-10 Finland

Other specified pulpit

1.5

9.0

256

1713

N05BA04

ATC

oxazepam; oral

1.2

9.0

1164

9812

H60.8

ICD-10 Finland

Other otitis externa

1.8

9.0

124

689

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

4.2

8.9

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.0

8.9

499

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

8.9

352

2514

ECA35

NOMESCO Finland

Complicated excision of lesion of gingiva

4.3

8.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.8

480

3613

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

8.8

854

6959

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

8.8

215

1389

R53

ICD-10 Finland

Malaise and fatigue

1.2

8.7

1009

8394

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

8.6

602

4702

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

2.8

8.6

152

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.8

8.6

123

690

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

8.6

1036

8662

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

8.5

371

2692

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

8.5

452

3389

K14.60

ICD-10 Finland

Glossopyrosis

2.9

8.5

131

A03FA02

ATC

cisapride; oral, rectal

1.4

8.5

339

2423

F01

ICPC

Eye pain

1.8

8.5

116

642

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

8.5

544

4199

G03CC04

ATC

estrone; systemic

1.7

8.5

156

941

SPAT1043

SPAT

Audiometry

1.4

8.5

468

3533

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

8.5

521

3998

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.9

8.5

110

600

P76

ICPC

Depressive disorder

1.5

8.4

224

1476

L04

ICPC

Chest symptom/complaint

1.5

8.4

263

1793

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

8.4

123

695

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

3.0

8.4

116

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

8.4

267

1828

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

8.4

428

3192

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.3

8.4

256

EJ1S1

NOMESCO Finland

Photography of tongue

4.9

8.3

K13.00

ICD-10 Finland

Cheilitis NOS

3.2

8.3

101

L40.2

ICD-10 Finland

Acrodermatitis continua

+∞

8.3

L41.9

ICD-10 Finland

Parapsoriasis, unspecified

+∞

8.3

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

8.3

238

1594

C10AA01

ATC

simvastatin; oral

1.2

8.3

2018

18043

K64.1

ICD-10 Finland

Second degree haemorrhoids

2.0

8.3

448

SPF20

NOMESCO Finland

Temporary relining of dentures

2.5

8.3

190

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

8.3

259

1768

C03CA01

ATC

furosemide; systemic

1.2

8.2

1334

11490

TKD00

NOMESCO Finland

Dilatation of urethra

2.6

8.2

179

C10AA05

ATC

atorvastatin; oral

1.2

8.2

2004

17921

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

8.2

1616

14177

B07.9

ICD-10 Finland

Verruca simplex

1.7

8.2

135

790

C10AC01

ATC

colestyramine; oral

1.8

8.2

120

679

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

8.2

231

1544

D11AH01

ATC

tacrolimus; topical

2.8

8.1

140

SPAT1324

SPAT

Screening procedure

1.3

8.1

675

5395

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

1.8

8.1

118

666

D06BB03

ATC

aciclovir; topical

1.6

8.1

206

1345

B48.8

ICD-10 Finland

Other specified mycoses

4.7

8.1

E03

ICD-10 Finland

Other hypothyroidism

1.5

8.1

273

1892

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

8.1

954

7950

SGB30

NOMESCO Finland

Other complicated root filling

1.4

8.1

403

2994

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

8.1

452

3420

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

8.0

1077

9096

A10BJ06

ATC

semaglutide; parenteral

1.6

8.0

198

1284

EAA30

NOMESCO Finland

Partial excision of lower lip

8.9

8.0

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

10.0

8.0

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.3

8.0

475

3625

D02

ICPC

Abdominal pain epigastric

1.5

8.0

260

1789

WZC00, ,

SPAT

1.4

8.0

409

3051

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.0

8.0

386

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.0

671

5372

J45

ICD-10 Finland

Asthma

1.4

8.0

434

3269

Y04

ICPC

Penis symptom/complaint other

3.5

8.0

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.0

1759

15585

N06AB03

ATC

fluoxetine; oral

1.3

7.9

525

4071

L13.0

ICD-10 Finland

Dermatitis herpetiformis

3.7

7.9

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

7.9

262

1812

L88

ICPC

Rheumatoid/seropositive arthritis

1.6

7.9

168

1054

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

7.8

498

3838

Z3231

NOMESCO Finland

Registered nurse

1.2

7.8

1171

10001

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

7.8

451

3428

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

7.8

236

1601

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

7.8

235

1593

L04AB01

ATC

etanercept; parenteral

2.3

7.8

252

S20.2

ICD-10 Finland

Contusion of thorax

1.5

7.8

205

1351

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

7.7

965

8088

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

4.2

7.7

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

2.2

7.7

266

D06BB10

ATC

imiquimod; topical

1.5

7.7

206

1363

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.5

7.7

203

1339

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

7.6

177

1132

UJH02

NOMESCO Finland

Anoscopy

1.6

7.6

178

1140

F41.00

ICD-10 Finland

Moderate panic disorder

2.3

7.6

254

R51.81

ICD-10 Finland

Facial pain NOS

1.8

7.6

104

577

XX9XT

NOMESCO Finland

Other radiological intervention

18.4

7.6

SPAT1216

SPAT

Assessment of functional ability

1.3

7.6

696

5631

EJB40

NOMESCO Finland

Hemiglossectomy

8.0

7.6

L80

ICD-10 Finland

Vitiligo

3.6

7.6

M01AH03

ATC

valdecoxib; oral

1.4

7.5

270

1893

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.5

356

2621

Z00.8

ICD-10 Finland

Other general examinations

1.4

7.5

301

2154

K90.0

ICD-10 Finland

Coeliac disease

1.7

7.5

120

697

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

7.5

133

795

K13.7

ICD-10 Finland

Other and unspecified lesions of oral mucosa

3.8

7.5

A05AA02

ATC

ursodeoxycholic acid; oral

2.1

7.5

321

N06AA12

ATC

doxepin; systemic

1.5

7.5

224

1516

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

7.5

373

2771

L71.9

ICD-10 Finland

Rosacea, unspecified

1.8

7.5

106

595

P25

ICPC

Phase of life problem adult

1.7

7.4

140

851

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

7.4

285

2025

SPAT1202

SPAT

Intra-articular injection

1.7

7.4

139

844

X15

ICPC

Vaginal symptom/complaint other

1.7

7.4

119

693

WZB00, ,

SPAT

1.4

7.4

264

1851

N05BA01

ATC

diazepam; systemic, rectal

1.3

7.4

557

4396

QXA70

NOMESCO Finland

Guidance related to rash and skin care

13.4

7.4

XQ899

NOMESCO Finland

Other assessment of skin

3.3

7.4

A10AE05

ATC

insulin detemir; parenteral

1.5

7.4

201

1335

A02BA04

ATC

nizatidine; systemic

1.4

7.3

326

2376

SGA05

NOMESCO Finland

Opening and preparing the root canals, extremely complicated And time consuming

1.5

7.3

209

1401

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

7.3

768

6312

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

7.3

230

1573

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

1.9

7.3

441

C10AA07

ATC

rosuvastatin; oral

1.2

7.3

1516

13336

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

7.3

172

1105

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

7.3

346

2550

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

+∞

7.3

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

+∞

7.3

L41.8

ICD-10 Finland

Other parapsoriasis

+∞

7.3

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

7.3

114

659

C09CA01

ATC

losartan; oral

1.2

7.3

1203

10364

D04

ICPC

Rectal/anal pain

2.1

7.3

305

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

7.3

366

L50.8

ICD-10 Finland

Other urticaria

2.0

7.3

366

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.0

7.2

339

EB4VA, ,

NOMESCO Finland

1.3

7.2

412

3125

K12.1

ICD-10 Finland

Other forms of stomatitis

15.7

7.2

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.8

7.2

536

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

7.2

423

3223

M01AB55

ATC

diclofenac, combinations; oral

1.4

7.2

302

2180

A06AD11

ATC

lactulose; oral

1.3

7.2

615

4933

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

7.2

419

3190

D01

ICPC

Abdominal pain/cramps general

1.3

7.2

460

3550

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

7.2

687

5586

XKC03

NOMESCO Finland

Water cystometry

1.7

7.2

138

844

SCC01

NOMESCO Finland

Fluoride application or other respective small prophylactic procedure

1.7

7.2

113

655

K07

ICPC

Swollen ankles/oedema

1.5

7.1

202

1352

N17

ICPC

Vertigo/dizziness

1.3

7.1

536

4229

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

7.1

322

2355

SDA05

NOMESCO Finland

Very demanding periodontal treatment

1.5

7.1

247

1723

L73.9

ICD-10 Finland

Follicular disorder, unspecified

3.3

7.1

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

7.1

390

R06.5

ICD-10 Finland

Mouth breathing

1.4

7.1

346

2563

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.1

609

4888

J01FA01

ATC

erythromycin; systemic

1.3

7.1

516

4056

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

7.1

267

1893

L04AB06

ATC

golimumab; parenteral

2.8

7.0

123

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.0

730

5993

L71.0

ICD-10 Finland

Perioral dermatitis

2.2

7.0

270

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.3

7.0

422

3228

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

7.0

3010

28048

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

7.0

389

2940

E0001A1, ,

ATC

2.0

7.0

330

C07AA05

ATC

propranolol; systemic

1.2

7.0

839

6996

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

7.0

355

2646

J01CF05

ATC

flucloxacillin; systemic

1.5

7.0

232

1605

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

4.4

7.0

A01

ICPC

Pain general/multiple sites

1.3

6.9

394

2988

S01XA18

ATC

ciclosporin; ophthalmic

2.6

6.9

153

K14.69

ICD-10 Finland

Tongue pain UNS

3.0

6.9

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.0

6.9

366

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

6.9

118

700

L60.0

ICD-10 Finland

Ingrowing nail

1.5

6.9

181

1193

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

6.9

374

2818

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.8

6.9

530

L30

ICD-10 Finland

Other dermatitis

1.8

6.9

494

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

6.9

701

5743

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.5

6.8

214

1464

U01

ICPC

Dysuria/painful urination

1.4

6.8

332

2460

B37.06

ICD-10 Finland

Candidal cheilitis

10.9

6.8

L16

ICPC

Ankle symptom/complaint

1.3

6.8

469

3659

N51.8*A60.0

ICD-10 Finland

Herpes simplex infection of the genitals in men

9.3

6.8

N06AB04

ATC

citalopram; systemic

1.2

6.8

917

7743

K04

ICPC

Palpitations/awareness of heart

1.5

6.8

220

1516

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

6.8

433

3342

J33.8

ICD-10 Finland

Other polyp of sinus

1.9

6.8

439

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.4

6.8

335

2488

C10AA04

ATC

fluvastatin; oral

1.3

6.7

374

2827

J01MA06

ATC

norfloxacin; oral

1.3

6.7

588

4729

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

6.7

494

3886

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

6.7

534

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

6.7

821

6860

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

6.7

855

7176

SCB01

NOMESCO Finland

Instructions for self-performed oral hygiene, short

2.7

6.7

121

XF402

NOMESCO Finland

ECG with work load test

1.3

6.7

461

3596

QBA

NOMESCO Finland

Incision or local destruction of lesion of skin of trunk

22.5

6.7

AN1

Coronary angiography

1.3

6.7

443

3438

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

6.6

353

2651

SPAT1255

SPAT

Intravenous administration of medicine

1.4

6.6

275

1983

SPF40

NOMESCO Finland

Removal and reattachment of crown or small bridge

1.8

6.6

471

A10AE04

ATC

insulin glargine; parenteral

1.3

6.6

371

2809

ZX198

NOMESCO Finland

Other local administration

2.3

6.6

212

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

6.6

232

1623

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

5.5

6.6

TAKUU, ,

NOMESCO Finland

2.6

6.6

145

N05CD07

ATC

temazepam; oral

1.3

6.6

493

3887

D01AE16

ATC

amorolfine; topical

1.3

6.6

518

4111

D06

ICPC

Abdominal pain localized other

1.4

6.6

344

2577

D06AX01

ATC

fusidic acid; topical

1.4

6.6

355

2673

J02AB02

ATC

ketoconazole; oral

1.7

6.6

113

672

D95

ICPC

Anal fissure/perianal abscess

2.8

6.6

111

Z50.1

ICD-10 Finland

Other physical therapy

1.5

6.5

223

1551

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

6.5

670

5489

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

6.5

222

1543

L20

ICPC

Joint symptom/complaint NOS

1.6

6.5

144

912

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

4.2

6.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

6.5

271

1954

SPA47

NOMESCO Finland

Precision impression for denture

1.7

6.5

111

659

K14.1

ICD-10 Finland

Geographic tongue

2.7

6.5

123

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

1.8

6.5

555

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

6.5

507

4022

M02AA10

ATC

ketoprofen; topical

1.2

6.5

719

5945

359

Kela drug reimbursment

Mirabegroni

2.6

6.5

129

L12.9

ICD-10 Finland

Pemphigoid, unspecified

5.3

6.4

A06AC51

ATC

ispaghula, combinations; oral

1.5

6.4

206

1416

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.1

6.4

260

WQ053, ,

NOMESCO Finland

69.9

6.4

L04AC16

ATC

guselkumab; systemic

69.9

6.4

L04AC18

ATC

risankizumab; parenteral

69.9

6.4

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

6.4

509

4044

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

3.4

6.4

D12

ICPC

Constipation

1.6

6.4

144

917

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

6.4

187

1263

WZC30

NOMESCO Finland

Teaching

1.2

6.4

675

5552

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

6.4

289

2117

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.4

420

3257

J01FA15

ATC

telithromycin; oral

1.3

6.4

409

3160

S15

ICPC

Foreign body in skin

1.4

6.4

260

1871

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.9

6.3

102

G03CB01

ATC

dienestrol; oral, vaginal

1.6

6.3

127

786

L09

ICPC

Arm symptom/complaint

1.5

6.3

186

1256

L01BB02

ATC

mercaptopurine; oral

2.4

6.3

160

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.7

6.3

574

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.3

6.3

347

2620

K59.0

ICD-10 Finland

Constipation

1.4

6.3

224

1571

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

2.8

6.3

108

EB1WA, ,

NOMESCO Finland

2.8

6.3

108

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

6.3

663

5448

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.5

6.3

196

1340

L04AC05

ATC

ustekinumab; parenteral

5.9

6.3

L85.3

ICD-10 Finland

Xerosis cutis

2.3

6.3

204

L12.8

ICD-10 Finland

Other pemphigoid

11.0

6.3

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.4

6.3

179

L90.9

ICD-10 Finland

Atrophic disorder of skin, unspecified

9.2

6.3

EEB00

NOMESCO Finland

Partial excision of maxilla

9.2

6.3

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

6.3

188

1276

XLD10

NOMESCO Finland

Gynaecological examination

2.9

6.3

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

+∞

6.2

WQ054, ,

NOMESCO Finland

+∞

6.2

299, ,

Kela drug reimbursment

+∞

6.2

C08CA02

ATC

felodipine; oral

1.3

6.2

396

3054

R31

ICD-10 Finland

Unspecified haematuria

1.3

6.2

366

2791

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.8

6.2

466

R15

ICD-10 Finland

Faecal incontinence

1.6

6.2

134

845

L92.0

ICD-10 Finland

Granuloma annulare

3.0

6.2

M01AB08

ATC

etodolac; oral

1.4

6.2

314

2341

L14

ICPC

Leg/thigh symptom/complaint

1.4

6.2

327

2454

Y29

ICPC

Genital symptom/complaint male other

3.1

6.2

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.1

6.2

271

N04BC05

ATC

pramipexole; oral

1.4

6.2

332

2499

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.6

6.2

129

808

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.9

6.2

403

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

6.1

511

4085

D10.39

ICD-10 Finland

Benign tumor in other or unspecified part of oral cavity UNS

3.2

6.1

K05.08

ICD-10 Finland

Another acute gingivitis

1.7

6.1

108

647

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

6.1

263

1909

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.8

6.1

491

X16

ICPC

Vulval symptom/complaint

2.2

6.1

233

S00.51

ICD-10 Finland

Superficial damage to other part of the oral cavity

4.1

6.1

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

6.1

364

2784

L20

ICD-10 Finland

Atopic dermatitis

1.8

6.1

477

L12.1

ICD-10 Finland

Cicatricial pemphigoid

12.5

6.1

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.6

6.1

138

882

SPAT1151

SPAT

Treatment of major wounds

2.1

6.1

240

K04.0

ICD-10 Finland

Pulpitis

1.4

6.1

310

2316

U71

ICPC

Cystitis/urinary infection other

1.4

6.0

288

2127

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.8

6.0

427

H01.0

ICD-10 Finland

Blepharitis

1.4

6.0

242

1736

K22.2

ICD-10 Finland

Oesophageal obstruction

2.4

6.0

164

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.6

6.0

127

797

SAE02, ,

NOMESCO Finland

2.5

6.0

140

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

6.0

138

884

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

768

1957

4.41

274.73

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

369

623

6.29

210.26

2.1

1.3

—

(3000494) Fungus identified in Specimen by Culture

1032

5360

2.15

94.91

1.8

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

176

332

5.45

88.65

1.5

20.14

20.45

u/ml

0.03

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

154

292

5.40

77.11

1.3

1.4

350.00

456.54

titre

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

152

285

5.46

77.05

1.3

1.4

56.47

61.11

titre

0.09

(3013707) Erythrocyte sedimentation rate by Westergren method

4046

34209

1.74

64.03

5.0

4.1

12.61

12.96

mm/h

0.82

3766

31500

(3013115) Eosinophils [#/volume] in Blood

2949

23225

1.60

59.63

6.7

5.8

0.20

0.19

e9/l

3.32

2642

20170

(3006315) Basophils [#/volume] in Blood

2866

22446

1.59

59.13

6.6

5.6

0.04

e9/l

1.86

2553

19200

(3001604) Monocytes [#/volume] in Blood

2857

22382

1.59

58.68

6.6

5.6

0.57

0.58

e9/l

1.35

2548

19157

(3019198) Lymphocytes [#/volume] in Blood

2912

22966

1.58

57.71

6.6

5.6

1.87

1.91

e9/l

0.84

2624

20119

(3037522) Nuclear Ab [Titer] in Serum

993

5946

1.82

57.42

1.4

1.3

597.71

544.63

titre

0.35

227

1338

(40760892) CBC W Ordered Manual Differential panel - Blood

2692

21034

1.56

54.15

7.2

6.1

—

(40768804) Tissue Pathology biopsy report

2487

19154

1.56

52.89

2.4

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1412

9670

1.62

48.90

1.4

1.2

1.46

1.68

u/ml

0.38

397

2515

(3013650) Neutrophils [#/volume] in Blood by Automated count

3188

26263

1.53

47.52

9.3

9.0

3.88

4.06

e9/l

5.38

2862

22764

(3037467) Urinalysis macro (dipstick) panel - Urine

3676

31381

1.54

45.18

5.3

4.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4062

35589

1.58

43.22

4.9

4.2

14.90

14.89

pmol/l

0.09

3686

32167

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4087

35928

1.57

42.14

8.3

7.6

78.09

78.80

u/l

0.40

3875

33760

(3018010) Neutrophils/100 leukocytes in Blood

2634

21234

1.47

40.92

6.8

5.7

56.72

57.22

1.42

2473

19763

(3006504) Eosinophils/100 leukocytes in Blood

2605

20956

1.47

40.90

7.0

5.8

3.05

2.85

4.30

2446

19452

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4644

42238

1.73

40.59

5.9

5.0

1.94

2.05

mu/l

1.17

4270

38469

(3019069) Monocytes/100 leukocytes in Blood

2615

21078

1.47

40.48

7.4

6.1

8.60

8.63

0.14

2454

19604

(3002030) Lymphocytes/100 leukocytes in Blood

2661

21559

1.46

39.88

7.1

5.9

28.04

27.78

0.63

2502

20087

(3022096) Basophils/100 leukocytes in Blood

2531

20311

1.47

39.85

7.0

5.8

0.72

0.68

2.77

2371

18812

(3007853) Bacteria identified in Skin by Aerobe culture

818

5171

1.69

37.61

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1200

8359

1.56

37.02

1.5

2.49

2.45

g/l

0.21

733

4907

(3031040) Bacteria [#/volume] in Urine by Automated count

3521

30357

1.46

36.47

5.3

4.7

75.64

2090.25

e6/l

6.51

434

(3048689) Calprotectin [Mass/mass] in Stool

824

5270

1.67

36.12

2.5

2.1

150.38

144.26

ug/g

0.18

649

4126

(3015171) Extractable nuclear Ab [Units/volume] in Serum

353

1732

2.11

35.89

1.3

1.2

1.84

1.18

u/ml

0.28

175

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4860

45221

1.78

33.41

16.6

14.5

21.33

23.64

mg/l

5.60

3997

35881

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

6.12

33.10

2.0

1.5

9.47

8.96

ug/l

0.31

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1884

14692

1.43

32.42

2.7

2.6

55.67

64.56

u/l

0.95

1728

13511

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1121

7908

1.53

32.02

1.3

33.07

35.27

iu/ml

0.25

364

2576

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2893

24408

1.40

31.31

6.0

6.3

10.95

11.20

umol/l

0.53

2738

23142

(3035350) Ketones [Presence] in Urine by Test strip

2670

22230

1.40

31.20

4.5

3.8

0.00

estimate

1.68

484

4348

(3021601) Nitrite [Presence] in Urine by Test strip

2669

22237

1.40

30.96

6.0

5.1

0.00

estimate

0.80

444

4058

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2382

19499

1.40

30.50

2.1

2.0

95.76

96.70

pmol/l

0.40

1196

9634

(3009261) Glucose [Presence] in Urine by Test strip

2689

22507

1.39

29.94

4.5

3.8

0.00

estimate

1.32

428

4011

(3024561) Albumin [Mass/volume] in Serum or Plasma

2466

20437

1.38

28.68

5.0

4.7

35.67

35.38

g/l

1.89

2307

18946

(3019150) Specific gravity of Urine by Refractometry

1305

9681

1.46

28.62

4.7

4.3

1.02

kg/l

0.12

205

1449

(3019550) Sodium [Moles/volume] in Serum or Plasma

5004

47293

1.84

28.13

18.7

16.8

139.68

139.73

mmol/l

0.75

4895

46148

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1048

7478

1.50

27.87

1.3

15.19

13.75

u/ml

0.14

415

2859

(3023103) Potassium [Moles/volume] in Serum or Plasma

5011

47414

1.84

27.56

18.8

17.0

3.97

mmol/l

0.22

4898

46188

(3005322) IgE [Units/volume] in Serum or Plasma

452

2639

1.78

27.22

1.3

322.36

190.98

u/ml

1.46

419

2420

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1037

7423

1.49

27.06

1.6

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2806

23901

1.36

26.72

6.4

6.7

1.21

1.22

mmol/l

1.03

2406

20234

(3026008) Bacteria identified in Urine by Culture

1885

15099

1.38

26.30

3.6

3.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2373

19724

1.36

26.24

2.5

2.2

78.30

79.22

nmol/l

0.88

2124

17571

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1811

14436

1.38

25.93

2.2

2.1

156.07

199.34

u/l

2.54

1683

13477

(3013826) Glucose [Moles/volume] in Serum or Plasma

3124

27163

1.36

25.49

4.6

6.73

6.71

mmol/l

0.19

2952

25515

(3022217) INR in Platelet poor plasma by Coagulation assay

2586

21864

1.35

25.24

14.9

15.1

1.25

1.26

inr

0.26

734

6250

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

265

1338

2.03

24.89

1.6

1.5

1.19

g/l

0.05

254

1266

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

258

1295

2.04

24.63

1.7

1.5

0.23

0.24

g/l

0.56

247

1226

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4576

42573

1.50

24.11

6.7

5.9

40.28

39.92

mmol/mol

1.86

4243

39161

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5067

48339

1.84

23.80

12.8

10.6

25.95

25.68

u/l

0.42

4911

46499

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4757

44674

1.56

23.47

5.3

4.8

6.00

5.95

mmol/l

1.85

4362

40499

(4200892) Spirometry reversibility

534

3408

1.63

23.01

1.5

1.4

—

(40768797) Stomach Pathology biopsy report

923

6660

1.47

22.70

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

406

2445

1.71

21.82

1.3

1.2

—

(3015736) pH of Urine

2142

17860

1.33

21.82

4.2

3.5

5.94

5.84

0.53

108

1165

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2047

16957

1.33

21.81

4.8

4.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4791

45196

1.55

21.69

5.3

4.6

4.66

4.73

mmol/l

5.18

4450

41555

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

114

427

2.71

21.36

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1386

10876

1.37

20.90

1.6

1.5

21.44

20.92

nmol/l

0.60

1194

9203

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4865

46145

1.57

20.43

5.7

5.1

2.73

2.78

mmol/l

2.89

4485

42229

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

241

1265

1.95

20.29

1.3

1.2

9.68

44.00

u/ml

3.22

(3011397) Hemoglobin [Presence] in Urine by Test strip

1366

10742

1.36

20.21

4.4

3.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1786

14626

1.33

20.16

3.5

3.2

34.26

35.44

u/l

0.19

1683

13836

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5043

48295

1.71

19.90

19.6

17.1

76.10

76.23

umol/l

0.10

5038

48282

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1689

13780

1.33

19.39

3.0

1086.36

1348.23

ng/l

2.61

1447

11839

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4744

44859

1.49

19.08

5.1

4.5

1.48

1.51

mmol/l

4.94

4372

40997

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1420

11352

1.34

18.58

2.4

2.3

2.86

2.99

mg/l

1.33

1218

9680

(3000570) Elastase.pancreatic [Mass/mass] in Stool

262

1457

1.84

18.49

1.4

272.05

278.43

ug/g

0.20

153

863

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

190

960

2.02

17.86

1.3

1.2

6.33

5.10

u/ml

0.12

(3007461) Platelets [#/volume] in Blood

5166

49974

1.86

17.50

25.2

21.5

249.60

252.14

e9/l

2.05

5051

48660

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2177

18570

1.29

17.50

3.0

2.8

131.02

134.17

ug/l

0.21

1991

17031

(3024731) MCV [Entitic volume]

5167

49993

1.86

17.40

25.1

21.4

91.25

91.24

0.06

5098

49247

(3026361) Erythrocytes [#/volume] in Blood

5167

49999

1.86

17.31

25.2

21.5

4.47

4.46

e12/l

1.59

5041

48517

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4591

43293

1.41

17.30

4.6

4.0

1.32

1.30

mmol/l

1.44

4207

39163

(3017143) Hepatitis C virus Ab [Presence] in Serum

604

4216

1.49

17.26

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

5162

49943

1.84

17.19

25.2

21.6

40.06

40.00

0.19

4718

46549

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2908

25765

1.28

17.14

2.8

2.7

—

(3042936) Bacteria identified in Isolate by Culture

857

6395

1.40

17.10

2.1

2.0

—

(3035941) MCH [Entitic mass]

5165

49993

1.84

17.00

25.1

21.4

30.36

30.31

1.01

5097

49244

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

509

3439

1.53

16.99

1.7

—

(3010813) Leukocytes [#/volume] in Blood

5165

49996

1.84

16.95

25.2

21.5

6.62

6.65

e9/l

0.46

5034

48507

(3000963) Hemoglobin [Mass/volume] in Blood

5166

50010

1.84

16.93

25.4

21.6

134.96

134.24

g/l

3.22

5098

49273

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2091

17808

1.29

16.80

4.0

3.6

66.18

72.36

ng/l

0.05

1446

12489

(36660697) Celiac disease serology panel - Serum

517

3529

1.51

16.44

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

814

6065

1.40

16.33

7.6

6.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

216

1176

1.87

16.32

1.4

1.3

2.88

6.71

u/ml

1.87

200

(3029937) Albumin [Presence] in Urine by Test strip

1469

11990

1.31

16.19

4.8

4.3

0.00

estimate

0.00

437

3937

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

241

1365

1.80

16.04

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

581

4090

1.47

15.86

2.4

2.2

366.03

374.49

nmol/l

0.48

520

3745

(3012516) Albumin [Mass/volume] in Urine

1679

13980

1.29

15.86

3.4

3.2

738.70

364.58

mg/l

1.54

1030

8595

(3019309) Folate [Moles/volume] in Red Blood Cells

1129

8904

1.34

15.79

1.7

1138.81

1175.07

nmol/l

0.69

853

6708

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

177

914

1.97

15.69

1.3

1.2

43.44

42.54

u/ml

0.03

106

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3221

29073

1.27

15.54

3.5

3.1

48.98

49.08

u/l

0.02

2987

26827

(3023420) DNA double strand Ab [Units/volume] in Serum

104

437

2.41

15.48

1.5

1.4

19.29

22.74

iu/ml

—

(3020961) Endomysium IgA Ab [Titer] in Serum

318

1969

1.65

15.37

1.1

156.25

207.98

titre

0.20

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

211

1164

1.85

15.32

1.4

1.3

5.52

4.97

u/ml

0.07

124

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2482

21755

1.26

15.22

5.4

5.9

1.21

mmol/l

0.80

2243

19743

(3020682) Albumin/Creatinine [Ratio] in Urine

1748

14704

1.28

15.05

3.9

3.8

8.85

9.20

mg/mmol

0.11

1060

8966

(3005719) IgG [Mass/volume] in Serum or Plasma

486

3337

1.50

14.99

2.6

2.8

10.66

10.41

g/l

0.59

453

3039

(40761535) Cells panel - Urine sediment

554

3907

1.47

14.95

3.8

3.5

—

(3009508) Creatinine [Moles/volume] in Urine

1728

14565

1.27

14.51

3.2

3.1

6.95

7.12

mmol/l

0.95

1460

12184

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1237

10051

1.30

13.71

1.7

1.17

1.26

mg/l

0.53

950

7730

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2452

21628

1.25

13.66

2.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

457

3178

1.48

13.22

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

4882

46930

1.44

12.99

16.3

13.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

841

6539

1.34

12.67

1.5

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1425

11915

1.27

12.37

2.8

2.6

3636.58

4930.96

umol/l

0.67

1234

10350

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1123

9140

1.29

12.09

3.9

3.7

403.82

463.84

ng/l

0.14

831

7263

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

551

4047

1.40

11.83

2.8

170.22

189.96

ng/l

0.61

509

3695

(3028026) IgM [Mass/volume] in Serum or Plasma

383

2631

1.49

11.77

1.6

1.8

1.29

1.38

g/l

0.42

348

2388

(3017181) Myelocytes/100 leukocytes in Blood

517

3760

1.41

11.75

4.1

3.9

0.97

0.92

0.11

163

1329

(3025159) Blasts/100 leukocytes in Blood

468

3352

1.43

11.58

4.2

4.0

0.29

0.34

0.07

120

940

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1226

10140

1.27

11.52

1.7

73287431.80

31669710.02

pmol/l

0.99

1007

8333

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

204

1214

1.71

11.51

1.6

1.5

0.33

5.87

iu/ml

0.64

266

(3025130) Human papilloma virus identified in Specimen

110

539

2.06

11.39

1.9

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

293

1915

1.56

11.36

5.1

5.5

0.92

0.90

0.27

277

1783

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

294

1929

1.55

11.21

5.1

5.4

1.67

1.64

0.22

278

1791

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

932

7491

1.30

10.93

1.9

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

473

3435

1.41

10.83

4.0

3.8

0.74

0.69

0.21

146

1148

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

408

2895

1.44

10.62

1.2

112.02

146.87

iu/ml

1.33

154

1087

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

347

2389

1.48

10.56

1.9

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

486

3571

1.40

10.39

4.2

4.0

0.08

0.12

0.56

134

1144

(3044889) 12 lead EKG panel

3524

32770

1.22

10.33

4.3

3.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

108

546

2.00

10.30

1.4

1.3

46.89

52.52

u/ml

0.11

(46235355) HIV 1 and 2 tests - Meaningful Use set

714

5585

1.32

10.19

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

379

2677

1.45

10.11

2.0

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

375

2650

1.45

9.98

2.5

2.4

—

(3021589) Normoblasts [#/volume] in Blood

2226

19855

1.21

9.95

10.7

9.4

0.00

e9/l

0.06

1876

16113

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

539

4064

1.36

9.84

2.2

2.3

5.90

6.89

ug/l

0.68

454

3534

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

2.94

9.74

1.8

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

220

1396

1.60

9.72

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

450

3302

1.40

9.70

2.3

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

631

4886

1.33

9.65

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

583

4488

1.34

9.27

2.2

0.21

g/l

0.36

542

4190

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

239

1567

1.55

9.19

1.4

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

191

1188

1.63

9.18

1.1

8.57

8.62

u/ml

0.00

113

(3008152) Bicarbonate [Moles/volume] in Arterial blood

406

2957

1.40

9.14

6.0

7.2

24.24

24.68

mmol/l

1.50

387

2799

(3013512) EKG study

1613

14037

1.21

9.12

4.6

4.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

813

6581

1.28

8.89

2.5

2.35

2.33

g/l

0.72

751

6073

(3018095) Leukocytes [#/volume] in Urine

1812

15987

1.20

8.79

4.1

3.7

89.64

114.83

e6/l

0.70

1326

11197

(3022948) Iron [Moles/volume] in Serum or Plasma

871

7124

1.27

8.73

2.6

2.5

13.07

12.85

umol/l

0.42

813

6632

(3003338) MCHC [Mass/volume]

3961

37497

1.21

8.67

22.2

18.9

332.21

331.65

g/l

3.74

3934

37223

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

245

1637

1.52

8.66

1.5

1.6

—

(3018418) pH of Serum or Plasma

1638

14333

1.21

8.65

3.6

4.1

7.40

0.04

271

2733

(3019060) Gas panel - Arterial blood

421

3115

1.38

8.64

4.3

5.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

182

1137

1.62

8.61

5.6

4.4

—

(4062490) Immunoglobulin typing, IgG

429

2.02

8.59

1.8

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

653

5170

1.30

8.47

3.8

4.3

234.13

247.23

u/l

2.10

605

4874

(3000850) Epithelial cells [#/volume] in Urine

1131

9569

1.23

8.34

2.7

2.6

4.52

6.07

e6/l

5.18

1010

8553

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

762

6171

1.27

8.27

2.6

22.50

22.35

0.10

614

5232

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

940

7817

1.25

8.12

2.9

2.7

0.86

1.26

e6/l

3.94

577

4410

(3047181) Lactate [Moles/volume] in Blood

225

1504

1.52

7.96

5.4

6.5

1.34

1.28

mmol/l

0.26

202

1319

(3020717) Zinc [Moles/volume] in Serum or Plasma

220

2.38

7.82

1.2

1.4

19.75

24.96

umol/l

0.68

205

(3026782) Osmolality of Urine

1061

8979

1.23

7.74

3.4

2.9

521.94

526.60

mosm/kgh2o

0.28

902

7675

(40758558) Short blood count panel - Blood

1346

11665

1.21

7.71

7.0

6.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

169

1069

1.60

7.65

1.8

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

383

2848

1.37

7.64

1.3

43.69

54.31

au/ml

—

165

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1447

12658

1.20

7.45

1.8

1.6

1.38

1.37

mmol/l

0.15

1228

10528

(3022145) Colonoscopy Study observation

656

5281

1.28

7.45

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

190

1243

1.55

7.44

1.2

105.45

142.13

titre

0.29

108

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

305

2197

1.41

7.36

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

433

1.93

7.36

1.8

1.3

0.32

0.41

g/l

1.70

305

(3028192) IgG subclass 2 [Mass/volume] in Serum

433

1.93

7.36

1.8

1.3

2.97

2.83

g/l

0.24

305

(3030467) Casts [#/volume] in Urine by Automated count

1445

12652

1.19

7.35

3.4

3.1

0.25

0.47

e6/l

6.96

1125

9532

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1291

11189

1.20

7.34

5.0

4.9

2.19

3.18

ug/l

1.42

1156

10019

(3002582) Erythrocytes [#/volume] in Urine

1552

13677

1.19

7.33

3.5

3.2

41.85

76.55

e6/l

2.47

1215

10376

(3015377) Calcium [Moles/volume] in Serum or Plasma

1834

16403

1.18

7.27

3.3

3.4

2.36

mmol/l

0.14

1592

14278

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

202

1347

1.52

7.26

1.9

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

105

594

1.78

7.23

1.3

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

505

3950

1.31

7.16

2.4

2.6

67.16

66.24

g/l

1.90

456

3577

(3027135) IgG subclass 1 [Mass/volume] in Serum

433

1.91

7.03

1.9

1.3

6.46

6.88

g/l

0.59

303

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

225

1546

1.48

7.01

1.6

493.33

300.54

titre

—

(3008898) HLA-B27 [Presence]

191

1269

1.52

7.00

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

187

1238

1.53

6.97

1.2

844.55

1058.67

titre

0.27

(3023520) Reticulocytes [#/volume] in Blood

491

3843

1.31

6.93

2.4

2.5

68.35

70.14

e9/l

0.55

380

2897

(3024980) IgG subclass 4 [Mass/volume] in Serum

115

677

1.71

6.91

1.8

1.5

0.64

0.76

g/l

0.66

508

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

3.05

6.87

1.9

8.48

8.88

mg/l

0.13

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

640

5187

1.27

6.86

1.8

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

311

2276

1.39

6.86

2.8

2.7

0.23

0.30

e6/l

0.76

303

2220

(3041096) Erythrocytes [Presence] in Urine by Automated

1334

11663

1.19

6.82

4.0

3.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

410

3137

1.33

6.80

2.6

2.4

23.58

24.34

au/ml

0.03

216

(3002385) Erythrocyte distribution width [Ratio]

4055

38749

1.19

6.75

19.5

17.2

15.25

15.26

0.04

3995

38041

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

637

5170

1.26

6.75

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

195

1317

1.50

6.63

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

372

1.95

6.61

1.2

2.40

3.45

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

394

1.92

6.56

1.2

61.00

32.61

u/ml

—

(42529406) Shigella sp [Presence] in Stool by Culture

195

1324

1.49

6.47

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

293

2.06

6.45

1.8

2.0

—

(3023368) Bacteria identified in Blood by Culture

1405

12390

1.18

6.44

4.2

4.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

115

691

1.68

6.44

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

245

1741

1.43

6.42

2.7

2.3

9.62

10.08

g/l

1.00

219

1538

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

192

1305

1.49

6.35

1.2

—

(44813793) Dust mix specific IgE antibody measurement

297

2.03

6.23

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

622

5082

1.25

6.22

2.5

1.77

1.81

0.48

547

4505

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4473

43241

1.21

5.99

15.1

13.6

78.63

78.46

ml/min/173m2

0.22

3764

35738

(3000330) Specific gravity of Urine by Test strip

313

2348

1.35

5.95

4.8

3.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

286

2.00

5.73

1.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

288

2149

1.36

5.68

3.9

3.3

25.34

mmol/l

0.00

282

2083

(3016502) Oxygen saturation in Arterial blood

578

4739

1.25

5.60

6.5

7.6

96.24

95.75

1.89

552

4548

(3017446) Testosterone [Moles/volume] in Serum or Plasma

318

2415

1.34

5.59

2.2

12.41

12.78

nmol/l

0.34

278

2147

(3004716) Salmonella sp identified in Stool by Organism specific culture

271

2010

1.37

5.56

1.3

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

290

1.98

5.53

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

368

2859

1.31

5.52

3.2

3.3

4.38

4.44

pmol/l

0.67

324

2522

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.63

5.47

1.0

—

(3017732) Neutrophils [#/volume] in Blood

400

3151

1.29

5.41

2.7

3.1

4.65

4.86

e9/l

0.15

314

2519

(3018572) Chloride [Moles/volume] in Blood

161

1093

1.49

5.41

6.4

7.4

105.01

105.12

mmol/l

0.10

147

970

(3039000) Anion gap in Blood

161

1093

1.49

5.41

6.4

7.4

11.31

11.15

mmol/l

0.24

147

970

(3052592) Norovirus Ag [Presence] in Stool

2.82

5.39

1.2

1.4

—

(3022621) pH of Urine by Test strip

388

3052

1.29

5.31

3.4

3.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.72

5.26

1.0

1.1

0.63

0.69

umol/24h

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

161

1101

1.48

5.23

1.3

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1859

1.37

5.22

2.7

2.3

3.72

3.63

g/l

0.30

227

1675

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1861

1.37

5.19

2.7

2.3

7.32

7.48

g/l

0.99

227

1674

(3025468) Yersinia sp identified in Specimen by Organism specific culture

101

625

1.63

5.13

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

835

7168

1.20

5.11

3.1

2.9

2.68

3.04

e6/l

0.64

476

3789

(3002173) Hemoglobin [Mass/volume] in Arterial blood

536

4408

1.24

5.06

6.9

8.0

121.18

120.65

g/l

0.24

520

4271

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

643

1.61

5.06

1.3

1.4

—

(3045414) Leukocytes [Presence] in Urine

281

2130

1.34

5.04

2.0

1.9

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

101

629

1.62

5.01

1.3

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

133

884

1.52

4.98

3.2

3.7

57.08

57.97

0.39

133

884

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.63

4.97

3.4

3.0

8.34

7.42

mg/l

0.35

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

117

2.49

4.94

1.0

1.1

86.00

88.34

0.10

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

628

5265

1.22

4.93

2.4

2.7

7.61

8.26

umol/l

0.35

546

4567

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

441

1.73

4.92

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

249

1860

1.36

4.92

2.7

2.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

325

1.86

4.88

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.86

4.88

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

443

1.73

4.85

1.6

1.3

15031.13

89271.97

e6/l

1.72

297

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

100

627

1.61

4.84

1.3

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

326

1.85

4.84

1.2

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

634

5333

1.21

4.81

6.4

7.2

5.07

5.10

kpa

0.28

597

5069

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

100

629

1.60

4.78

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

462

3764

1.25

4.75

2.6

62.42

64.28

ml/min/173m2

0.57

201

1476

(36304419) Bacteria [Presence] in Urine

1369

12298

1.15

4.72

3.3

3.1

—

(3003396) Base excess in Arterial blood by calculation

632

5325

1.21

4.72

6.4

7.2

1.11

1.13

mmol/l

0.06

487

4231

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.83

4.71

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.83

4.71

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.83

4.71

1.2

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

632

5331

1.21

4.66

6.4

7.1

12.32

12.34

kpa

0.03

596

5067

(3024522) Salmonella sp identified in Specimen by Organism specific culture

100

634

1.59

4.64

1.3

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

161

1129

1.44

4.64

1.9

1.6

14029.67

10689.83

e6/l

0.53

114

816

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

115

2.44

4.62

1.0

1.3

93.92

87.43

0.32

(3019225) pH of Specimen

596

5005

1.21

4.61

4.1

4.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

255

1936

1.33

4.55

2.3

1.9

40.39

39.48

u/l

0.30

222

1699

(3006184) Hemoglobin [Mass/volume] in Capillary blood

146

1011

1.46

4.50

2.4

2.1

130.92

127.79

g/l

0.76

102

717

(3011412) CD3 cells [#/volume] in Blood

410

1.72

4.43

1.9

2.3

1.18

1.17

e9/l

0.01

372

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1014

8956

1.16

4.37

4.5

4.2

21.24

21.85

0.62

452

4348

(3020779) Urea [Moles/volume] in Serum or Plasma

485

4016

1.23

4.31

6.8

7.3

9.20

9.92

mmol/l

1.55

457

3828

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

170

1222

1.40

4.30

2.3

2.0

10.20

11.73

mg/l

1.86

154

1118

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.51

4.20

1.0

1.1

2.47

1.77

u/ml

—

(3012544) pH of Venous blood

508

4240

1.22

4.19

3.9

3.7

7.39

7.38

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

231

1754

1.33

4.15

2.7

2.3

2.79

2.97

g/l

2.22

207

1569

(3003458) Phosphate [Moles/volume] in Serum or Plasma

702

6049

1.18

4.10

5.5

5.7

1.02

1.04

mmol/l

0.59

660

5597

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

736

1.50

4.06

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

111

2.35

3.98

1.8

1.18

2.21

ug/l

3.21

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

239

1.89

3.96

2.3

2.7

39.09

41.19

0.33

138

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

137

2.20

3.94

1.3

0.30

0.31

g/l

0.16

109

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

168

1227

1.38

3.90

1.6

1.3

—

(3000060) B lymphocytes [#/volume] in Blood

2.51

3.87

1.5

2.0

140.00

156.59

e6/l

0.18

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

206

1.95

3.85

1.6

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

231

1775

1.31

3.85

1.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

242

1.87

3.82

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

338

2730

1.25

3.80

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

543

4611

1.20

3.75

1.8

1.7

1.53

1.47

1.02

481

4013

(3012095) Magnesium [Moles/volume] in Serum or Plasma

871

7696

1.16

3.71

2.9

3.2

0.81

mmol/l

0.38

811

7175

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

526

1.57

3.70

1.8

1.5

57.37

58.80

0.12

331

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

3.60

3.69

1.1

1.0

0.00

0.73

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

778

1.46

3.66

1.3

13.04

12.88

u/l

0.04

632

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

155

2.07

3.66

1.7

1.5

15.78

15.74

pmol/l

0.01

131

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

268

1.80

3.64

1.8

2.5

0.21

0.22

e9/l

0.19

237

(3021901) Oxygen saturation in Capillary blood

115

798

1.45

3.59

2.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

248

1944

1.29

3.58

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

367

1.67

3.57

1.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

105

717

1.47

3.56

1.7

1.4

—

(3017704) Immunofixation for Urine

264

1.79

3.51

1.9

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

213

1644

1.31

3.47

3.1

4.0

1.36

mmol/l

0.02

208

1618

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

165

1228

1.35

3.45

1.7

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

152

2.05

3.45

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

106

2.27

3.44

2.1

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1011

9074

1.14

3.44

2.9

3.0

2.45

2.46

mmol/l

2.51

896

7955

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

281

1.75

3.42

1.8

2.4

451.35

542.68

e6/l

0.71

239

(3000492) Spirometry study

500

4255

1.19

3.39

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

388

1.63

3.39

1.0

1.1

7.12

2.77

u/ml

0.62

143

(3019832) Treponema pallidum Ab [Presence] in Serum

278

2227

1.26

3.39

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

420

1.60

3.36

1.1

1.04

2.70

u/ml

2.16

183

(3037121) Protein [Mass/volume] in Urine

208

1608

1.31

3.36

2.5

3.0

0.38

0.30

g/l

0.59

605

(3018677) aPTT in Platelet poor plasma by Coagulation assay

799

7071

1.15

3.33

1.9

2.1

29.55

29.71

0.28

767

6848

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

150

1107

1.37

3.32

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

149

1099

1.37

3.31

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.92

3.29

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

270

1.75

3.27

1.1

4.47

10.83

iu/ml

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

441

1.57

3.21

3.4

3.6

56.31

56.72

0.05

380

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

326

1.66

3.16

1.4

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

180

1380

1.31

3.11

2.6

3.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

479

4094

1.19

3.11

3.7

5.83

5.84

kpa

0.04

468

3972

(3044927) Protein electrophoresis panel - Urine

501

1.52

3.10

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

556

4814

1.17

3.09

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

309

2534

1.23

3.09

8.2

9.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.80

3.08

1.6

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

119

2.11

3.03

1.0

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

330

1.64

3.03

1.9

2.3

43.32

38.63

1.30

325

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

210

1.82

3.03

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

10.01

2.98

1.0

1.2

1076.00

1740.00

titre

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

490

1.52

2.97

1.1

2.11

1.43

u/ml

0.24

236

(3004119) Hemoglobin [Mass/volume] in Venous blood

327

2711

1.22

2.95

3.9

3.2

127.60

127.98

g/l

0.12

319

2634

(3002032) Base excess in Venous blood by calculation

476

4087

1.18

2.94

3.7

1.91

2.06

mmol/l

0.46

415

3481

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

648

1.44

2.91

1.5

1.9

180.40

203.60

pmol/l

1.50

612

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

139

1039

1.35

2.89

2.3

2.2

77.75

93.91

ug/min

0.30

622

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

227

1814

1.26

2.88

1.9

2.0

2.30

2.07

ug/l

0.12

191

1609

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

337

2811

1.21

2.87

3.1

3.6

5.10

5.16

kpa

0.53

318

2671

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

286

3466

0.82

2.87

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

105

751

1.41

2.86

1.8

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

105

751

1.41

2.86

1.8

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

706

1.41

2.75

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

648

1.43

2.74

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

172

1337

1.30

2.73

1.5

—

(3037756) Immunofixation for Serum or Plasma

131

980

1.35

2.72

1.8

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

181

1.83

2.72

1.1

26.85

0.82

u/ml

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

180

2281

0.78

2.71

1.6

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

601

1.44

2.68

1.3

—

nmol/l

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

175

1.83

2.67

1.2

2.1

139.00

152.65

0.54

162

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.75

2.67

1.7

2.2

33.07

18.57

mg/l

—

(3044941) Cell count panel - Synovial fluid

101

729

1.39

2.63

1.5

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

352

1.57

2.61

1.2

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

120

2.00

2.60

1.3

41.85

33.47

0.48

(3014599) Egg white IgE Ab [Units/volume] in Serum

177

1.81

2.59

1.0

10.13

0.43

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

260

1.66

2.56

1.4

1.7

5.06

6.91

u/l

1.59

216

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.00

2.56

1.0

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

330

1.58

2.56

1.2

1.3

—

(3009343) pH of Capillary blood

329

2775

1.20

2.53

3.1

3.6

7.41

7.42

0.63

354

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

186

1477

1.27

2.53

2.4

2.2

38.42

37.57

g/l

1.17

160

1288

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

676

1.40

2.52

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

390

3341

1.18

2.51

3.3

3.0

4.51

4.57

kpa

0.23

378

3229

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

469

1.48

2.50

1.4

1.3

40.48

34.44

u/l

0.66

376

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

318

2677

1.20

2.50

3.1

3.5

1.48

1.87

mmol/l

0.93

228

2010

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

788

1.37

2.49

1.6

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

357

1.55

2.47

1.0

288.92

292.51

mg/l

0.14

320

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

588

1.42

2.43

1.1

1.53

g/l

0.06

524

(3028679) Herpes simplex virus Ab [Presence] in Serum

189

1.75

2.40

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

674

1.39

2.40

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

440

3822

1.16

2.40

3.4

3.7

91.28

89.98

ng/l

0.10

376

3249

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

124

1.94

2.39

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.34

2.39

1.1

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.64

2.36

1.8

2.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.12

2.36

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

244

1.64

2.33

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

143

1111

1.29

2.33

1.5

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

323

1.55

2.31

1.2

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.31

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

129

991

1.31

2.29

1.3

3.79

3.80

mmol/l

0.05

118

925

(3040151) Glucose [Moles/volume] in Capillary blood

488

1.44

2.26

3.4

5.2

7.32

7.26

mmol/l

0.05

400

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.02

2.25

1.2

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

119

907

1.32

2.24

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

136

1057

1.29

2.23

1.7

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

416

1.47

2.21

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

303

1.56

2.21

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

2.18

1.1

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

185

1498

1.24

2.17

3.3

2.78

1.99

ratio

0.24

123

(3003888) Timothy IgE Ab [Units/volume] in Serum

545

1.40

2.12

1.0

1.1

7.41

3.89

u/ml

0.69

252

(3010838) Calcium [Moles/time] in 24 hour Urine

120

924

1.31

2.12

1.8

1.9

4.61

5.10

mmol/24h

1.04

101

804

(3020891) Body temperature

224

1859

1.21

2.09

3.6

4.6

—

(3000012) Reticulocyte production index

624

1.37

2.07

1.7

2.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

447

1.44

2.07

3.5

3.9

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

143

1132

1.27

2.05

1.4

1.3

532.21

534.93

mg/l

0.03

134

1064

(3042517) Benzodiazepines panel - Urine

3.50

2.05

1.3

1.5

—

(3021788) Differential panel - Synovial fluid

108

825

1.32

2.04

1.8

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

122

949

1.29

2.02

1.7

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

636

1.36

2.01

1.1

3.36

1.79

u/ml

0.47

324

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

118

1.87

2.01

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

185

1.68

2.00

1.3

5.6

55.14

1118.20

mg/l

0.50

138

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

361

1.47

1.97

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

280

1.54

1.97

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

511

1.39

1.97

1.9

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

511

1.39

1.97

1.9

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

622

1.36

1.96

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

313

1.51

1.95

2.0

1.8

8.56

10.36

umol/l

0.28

217

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

188

1546

1.22

1.95

3.4

3.3

40.94

54.87

mg/l

0.62

159

1258

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

281

1.53

1.94

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

246

2077

1.19

1.94

1.6

1.7

1.45

1.58

g/l

1.37

206

1776

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

172

1402

1.23

1.94

2.5

2.3

0.03

0.02

g/l

0.43

160

1288

(3021387) Prolactin [Units/volume] in Serum or Plasma

123

964

1.28

1.93

1.7

287.47

318.07

mu/l

0.57

109

874

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

134

1063

1.27

1.91

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

121

948

1.28

1.91

1.3

251.68

218.54

miu/ml

0.41

427

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

180

1.67

1.91

2.6

1.9

29.69

172.74

ug/l

0.46

165

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

191

1580

1.22

1.88

2.4

2.2

278.29

662.74

ug/l

1.73

177

1485

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

352

3071

1.16

1.87

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

114

1.85

1.86

1.3

1.1

—

(3023419) Bacteria identified in Sputum by Culture

724

1.32

1.85

2.8

2.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

733

1.32

1.85

4.3

3.5

1.68

1.56

0.14

661

(3034860) Kappa light chains.free [Mass/volume] in Serum

187

1547

1.22

1.84

3.4

3.3

43.99

92.45

mg/l

0.72

156

1259

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

192

1596

1.21

1.81

2.5

2.3

1.06

0.92

g/l

0.19

168

1379

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

188

1560

1.21

1.80

2.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

529

1.37

1.79

1.2

7.58

7.42

mmol/l

0.16

462

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

160

1307

1.23

1.79

1.8

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

231

1.56

1.78

1.1

1.3

424.43

275.25

u/l

0.23

213

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

161

1318

1.23

1.77

2.5

2.3

0.00

g/l

0.50

149

1209

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

280

1.50

1.76

1.3

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.90

1.75

1.9

1.5

126.61

115.42

ng/l

0.17

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.90

1.75

1.1

12.56

9.77

u/ml

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

592

1.34

1.74

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

665

6068

1.11

1.74

5.1

4.6

32.34

32.86

0.61

446

4047

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.92

1.72

1.0

1.4

3.37

4.20

nmol/l

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

620

1.33

1.71

1.5

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

110

868

1.27

1.68

6.0

5.3

144.53

635.75

iu/ml

1.96

121

(3008401) Mugwort IgE Ab [Units/volume] in Serum

527

1.35

1.68

1.0

1.1

1.91

1.33

u/ml

0.26

213

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

300

1.47

1.67

1.3

2.86

1.33

u/ml

0.34

178

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

119

1.77

1.65

1.3

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

188

1.60

1.65

1.2

1.3

147.15

151.27

mmol/24h

0.11

188

(3008757) Leukocyte morphology finding [Identifier] in Blood

503

1.36

1.65

3.9

4.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

595

0.69

1.63

3.4

5.1

365.26

363.37

umol/l

0.02

522

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

124

998

1.25

1.62

1.4

25.33

28.79

e6/l

0.08

759

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

158

1.65

1.62

2.2

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.38

1.61

1.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

609

1.32

1.61

4.1

6.6

10.56

11.94

mg/l

1.68

566

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

803

1.28

1.60

1.8

1.6

—

(4034850) Laboratory test

182

1526

1.20

1.60

11.2

9.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

113

1.77

1.60

1.3

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

121

973

1.25

1.59

2.8

2.4

16.17

0.00

486

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

124

1000

1.25

1.59

1.5

779.41

1226.79

e6/l

0.35

101

803

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

532

1.34

1.59

1.2

58.51

62.07

u/l

0.24

478

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

157

1301

1.21

1.57

2.6

2.3

0.00

g/l

-0.00

146

1207

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

339

1.42

1.54

1.4

1.3

2.09

2.06

mmol/l

0.11

317

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

249

1.49

1.52

1.3

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1197

11288

1.08

1.51

2.4

2.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.86

1.50

1.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

625

1.30

1.50

2.0

2.1

42.76

24.05

mg/l

1.35

162

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

687

1.29

1.49

1.3

0.66

2.90

nmol/l

0.69

662

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

168

1409

1.20

1.49

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

504

1.33

1.48

1.8

1.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

115

930

1.24

1.47

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

115

930

1.24

1.47

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1549

14757

1.07

1.47

2.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

716

1.28

1.46

2.3

2.0

7820.41

4326.41

u/l

0.29

307

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

454

1.35

1.45

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

2.37

1.45

2.9

3.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

150

1249

1.21

1.45

2.2

2.5

3.58

3.55

g/l

0.13

142

1182

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

294

2588

1.14

1.44

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

236

1.49

1.44

1.1

1.0

—

(3028433) Virus identified in Specimen by Culture

148

1.62

1.43

1.2

—

(3049717) Cytology report of Urine Cyto stain

193

1649

1.18

1.41

2.2

2.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

729

1.27

1.41

2.2

1.9

1.63

1.66

mmol/l

0.16

711

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

102

819

1.25

1.40

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.25

1.40

1.3

1.2

—

652.22

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

246

1.47

1.39

1.3

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

457

0.68

1.38

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.20

1.36

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

310

0.61

1.34

1.5

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

392

1.36

1.34

2.0

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.91

1.33

10.8

7.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

674

1.27

1.31

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

507

1.31

1.30

2.4

2.3

1.13

1.20

g/24h

0.09

238

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.09

1.30

1.2

2.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

106

1.70

1.29

8.9

7.7

—

(3013637) Mi-2 Ab [Presence] in Serum

106

1.70

1.29

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

106

1.70

1.29

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

106

1.70

1.29

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

106

1.70

1.29

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

284

1.41

1.29

1.9

2.5

816.57

678.67

e6/l

0.64

271

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

243

1.44

1.27

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

243

1.44

1.27

1.3

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.72

1.27

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.79

1.27

1.2

1.3

—

120.31

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

146

1.58

1.25

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

439

4003

1.11

1.22

3.5

3.9

1.23

mmol/l

0.96

386

3484

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

720

0.76

1.22

1.6

1.5

—

(3012898) Urea [Moles/volume] in Urine

2.16

1.21

1.3

165.00

149.45

mmol/l

—

(3022313) Gas panel - Capillary blood

230

2021

1.14

1.20

3.2

3.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

238

1.43

1.20

1.1

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

323

2902

1.12

1.19

7.6

8.7

1.39

1.36

0.22

318

2885

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.11

1.18

2.6

1.7

—

(3045424) Erythrocytes [Presence] in Urine

793

1.23

1.17

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

785

1.23

1.16

1.6

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

174

1.50

1.15

1.1

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

562

1.27

1.14

1.1

2.63

3.62

u/ml

0.36

224

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.4

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

242

1.41

1.11

1.4

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

494

1.28

1.10

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

309

2784

1.12

1.10

1.7

—

(3010503) CD19 cells [#/volume] in Blood

277

1.37

1.09

2.2

2.4

0.22

0.28

e9/l

0.17

266

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

407

1.31

1.09

1.5

1.4

26.18

30.63

0.47

253

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.95

1.08

1.4

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

286

1.37

1.08

1.1

1.29

11.26

nmol/l

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

630

1.24

1.08

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

177

1.47

1.07

2.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

347

1.33

1.07

1.0

0.62

0.26

u/ml

0.28

104

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

374

1.31

1.05

1.1

—

(21494755) Public health laboratory ask at order entry panel

293

3246

0.90

1.05

1.3

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

472

4358

1.09

1.04

2.4

2.3

45.85

49.33

u/l

0.08

398

3709

(3014051) Protein [Presence] in Urine by Test strip

148

1276

1.16

1.04

2.7

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

455

1.28

1.03

3.2

2.9

—

(3011288) Drugs identified in Urine by Screen method

571

1.25

1.03

1.9

2.4

—

(3004775) Volume in Urine collected for unspecified duration

341

1.32

1.02

2.4

2.3

720.68

630.19

0.51

230

(3047007) Chlamydophila sp Ab [Presence] in Serum

590

1.24

1.01

1.3

1.2

—

(3016750) Collection duration of Urine

247

1.38

1.01

2.1

2.2

480.74

494.37

min

0.35

187

(3035933) Granulocytes/100 leukocytes in Blood

106

0.47

1.01

1.2

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

147

1.50

1.00

1.5

1.7

0.54

0.38

ug/l

0.71

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

180

1.45

1.00

4.1

2.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

360

1.31

1.00

1.2

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.84

0.98

1.0

1.1

1.65

1.72

umol/24h

—

(3006270) Folate [Moles/volume] in Blood

414

1.28

0.98

1.1

1.2

384.85

355.53

nmol/l

0.36

352

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

539

1.25

0.98

1.9

14.36

24.99

ug/l

3.39

532

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.17

0.98

2.0

1.9

—

0.20

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

131

1125

1.17

0.98

2.4

2.9

1.64

1.59

mg/l

0.27

117

1022

(3023323) Follitropin [Units/volume] in Serum or Plasma

159

1387

1.15

0.97

1.5

1.3

28.72

34.85

iu/l

1.84

143

1197

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

362

1.30

0.97

1.3

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.63

0.97

1.1

1.3

0.59

51.60

mg/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.89

0.94

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.61

0.93

9.7

7.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

198

1759

1.13

0.93

3.3

3.9

24.64

24.96

mmol/l

0.84

182

1627

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

209

1.39

0.92

1.6

1.7

2.68

6.29

nmol/l

0.91

176

(3036670) Protein [Mass/volume] in Synovial fluid

142

1.48

0.92

1.3

1.2

37.97

38.77

g/l

0.07

(3023183) Ammonium ion [Moles/volume] in Plasma

107

910

1.18

0.91

3.1

2.8

33.97

34.87

umol/l

0.15

819

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.14

0.91

1.2

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

307

2800

1.10

0.91

2.9

3.9

35.03

61.68

u/ml

2.83

294

2689

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

110

1.55

0.90

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

838

1.18

0.90

1.6

1.8

0.89

0.84

nmol/l

0.26

706

(3020191) Ethanol [Moles/volume] in Serum or Plasma

314

1.31

0.89

1.3

1.5

1.37

1.14

promille

0.39

240

(3035637) Corticotropin [Mass/volume] in Plasma

555

1.23

0.89

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

109

931

1.17

0.89

1.3

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

174

1539

1.13

0.89

2.5

3.1

0.35

u/ml

0.03

882

(3016228) CD19 cells/100 cells in Blood

185

1.41

0.89

2.1

8.19

8.49

0.04

177

(3033705) Calcium.ionized [Moles/volume] in Venous blood

538

1.23

0.88

3.1

2.4

—

(3008295) Osmolality of Serum or Plasma

493

1.24

0.88

1.8

1.4

282.16

276.55

mosm/kgh2o

1.37

382

(21494434) Karyotype in Bone marrow

413

1.26

0.87

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

716

0.81

0.87

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

309

0.71

0.84

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

154

1.43

0.83

1.0

0.94

2.10

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

163

1.41

0.81

1.7

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

223

1.35

0.81

1.5

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

224

2026

1.11

0.81

2.6

0.66

0.64

0.24

224

2011

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

363

0.74

0.80

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

401

1.25

0.79

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

401

1.25

0.79

1.3

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

401

1.25

0.79

1.3

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

410

1.25

0.79

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

437

1.24

0.79

1.1

—

102.17

—

(4281824) Cell count and differential, peritoneal fluid

597

0.80

0.79

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.82

0.79

1.3

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.67

0.78

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

629

1.20

0.78

2.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

295

1.29

0.78

1.3

1.2

29.52

21.10

u/l

0.44

248

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

349

1.26

0.77

1.3

1.2

325.00

169.53

titre

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

791

0.83

0.76

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

287

1.29

0.76

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

385

1.25

0.76

1.2

1.3

1.47

1.46

nmol/l

0.02

347

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.77

0.76

1.0

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

558

1.20

0.76

2.9

3.3

6.46

5.52

nmol/l

0.12

546

(3035285) Chloride [Moles/volume] in Venous blood

550

1.20

0.74

3.1

2.3

106.17

105.29

mmol/l

0.84

541

(3041354) Potassium [Moles/volume] in Venous blood

550

1.20

0.74

3.1

2.3

4.02

4.05

mmol/l

0.21

541

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.84

0.73

1.0

1.2

6.14

18.18

u/l

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.00

0.72

1.2

—

1.17

—

(3005570) Glucose [Moles/volume] in Urine

488

1.21

0.72

1.8

1.9

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.61

0.72

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

110

0.54

0.71

1.0

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

110

0.54

0.71

1.3

1.9

—

(3017569) Oxygen content in Arterial blood

203

1.33

0.70

1.3

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

601

1.18

0.69

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

602

1.18

0.68

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

130

1154

1.13

0.68

3.3

3.5

—

(3033799) Differential panel - Peritoneal fluid

144

1.39

0.67

1.9

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

736

0.84

0.67

1.4

1.2

299.26

282.56

u/ml

0.19

446

(3028308) Erythrocytes [#/volume] in Pleural fluid

485

0.80

0.67

1.5

84313.41

64144.04

e6/l

0.12

290

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

438

1.21

0.67

4.6

4.9

105.20

85.06

u/ml

0.11

126

(3051611) Lipemic interference index of Serum or Plasma

484

1.20

0.66

2.7

3.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.79

0.66

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

394

1.22

0.65

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.57

0.65

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

179

1968

0.91

0.64

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

198

1.31

0.64

1.5

1.4

3.71

3.67

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

441

1.20

0.63

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

415

0.79

0.63

1.6

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

607

1.17

0.63

2.0

1.8

90.07

89.56

0.28

598

(3024891) Influenza virus A+B Ag [Presence] in Specimen

117

1038

1.13

0.63

1.2

—

(40768795) Lymph node Pathology biopsy report

513

0.82

0.62

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

128

1143

1.12

0.62

1.9

1.8

6.09

4.90

iu/l

0.33

395

(3045788) Cell count panel - Pleural fluid

425

0.80

0.62

1.4

1.5

—

(3014271) Vancomycin [Susceptibility]

243

1.28

0.62

3.1

2.8

—

(40757373) Influenza virus identified in Isolate

103

0.58

0.62

1.0

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1070

0.88

0.61

1.3

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

147

1.36

0.61

6.3

3.6

45.93

53.61

0.75

141

(3017509) Phencyclidine [Presence] in Urine

1.67

0.61

6.2

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

298

1.24

0.60

1.6

78.03

81.64

umol/l

0.29

298

(3009871) Measles virus Ab [Titer] in Serum

122

1.39

0.60

1.8

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

4.7

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.59

0.0

1.0

—

88.47

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.59

0.0

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.59

0.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.59

0.0

6.8

—

123.71

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

136

1224

1.11

0.59

2.3

2.4

187.50

196.15

0.54

125

1165

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

464

1.19

0.58

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

219

1.28

0.58

4.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

228

1.27

0.58

1.1

1.15

1.12

u/l

0.06

122

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

291

1.24

0.58

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

456

1.19

0.57

1.1

—

5.04

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.48

0.57

1.3

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.46

0.56

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

485

1.18

0.56

1.3

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

185

1.30

0.56

1.1

91.14

454.97

ng/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

329

1.22

0.55

1.5

9.78

5.92

u/l

0.87

269

(3023410) Appearance of Cerebral spinal fluid

440

1.18

0.54

1.4

1.5

—

(3002256) Pathology report gross observation

592

6181

0.95

0.53

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

260

0.77

0.52

1.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

1491

15273

0.97

0.52

3.3

2.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

250

1.24

0.52

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

714

1.14

0.51

1.4

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.50

0.51

1.7

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

499

1.16

0.51

1.8

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

866

1.12

0.51

1.6

1.7

—

(1616796) Gas panel - Central venous blood

111

1000

1.11

0.50

3.4

3.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

213

0.75

0.49

1.3

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

156

0.70

0.49

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.49

0.49

1.1

—

(3011985) Renin [Units/volume] in Plasma

632

1.14

0.49

1.5

1.4

39.25

55.04

mu/l

0.77

560

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.56

0.49

3.1

2.5

0.71

0.51

u/field

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.56

0.49

1.9

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

262

1.22

0.48

1.2

1.1

1.09

1.05

ratio

0.59

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

163

1.29

0.48

1.2

1.1

1909.95

1545.89

miu/ml

0.86

163

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

299

1.21

0.47

1.1

44.41

39.65

mg/l

0.24

251

(3022689) Creatine [Moles/volume] in Urine

128

1.33

0.47

1.9

1.4

—

(3012501) Base excess in Blood by calculation

114

1033

1.11

0.47

3.7

4.2

2.43

2.70

mmol/l

0.53

724

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

387

0.83

0.47

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

457

1.16

0.47

1.9

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

655

0.87

0.46

1.7

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.46

1.0

1.2

—

(3025577) Chromium [Mass/volume] in Blood

321

0.81

0.46

2.2

2.1

1.87

2.26

ug/l

0.29

275

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

386

0.83

0.46

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

129

1.32

0.45

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

243

0.78

0.45

1.6

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.59

0.45

1.8

1.2

—

(3019977) pH of Arterial blood

246

1.22

0.45

2.0

3.3

7.42

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

385

0.83

0.45

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

385

0.83

0.45

1.5

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.40

0.45

1.4

1.6

—

(40768793) Breast Pathology biopsy report

117

1281

0.91

0.44

1.3

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

592

1.13

0.43

1.3

305.80

343.70

pmol/l

0.27

514

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.61

0.43

1.6

1.47

1.34

umol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

670

6477

1.04

0.41

2.9

3.0

0.76

ug/l

0.00

428

4302

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

185

1.24

0.41

1.5

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

185

1.24

0.41

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

185

1.24

0.41

1.5

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

1208

11801

1.03

0.41

3.8

92.33

91.01

1.07

1169

11498

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.1

—

20.39

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1004

0.90

0.41

4.0

3.5

21.40

26.55

mg/l

0.97

615

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.08

—

(3027008) Opiates [Presence] in Urine

872

1.10

0.40

1.6

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.33

0.40

2.9

1.9

10.26

19.47

umol/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

168

1.25

0.40

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

159

1.26

0.40

1.9

2.6

27.08

28.90

umol/l

0.40

117

(46236302) HLA-C [Type] by High resolution typing

0.00

0.40

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.40

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

0.40

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.40

0.0

1.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

17.74

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

4.5

—

3.10

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

115

1252

0.92

0.39

1.2

1.3

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.43

0.39

1.2

1.1

—

5.13

u/l

—

(3013862) HLA-DP [Type]

0.00

0.39

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.39

0.0

5.5

—

371.21

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.39

0.0

2.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

187

1.23

0.38

1.5

2.0

—

(3004451) EKG impression Narrative

242

1.20

0.38

1.2

1.3

—

(3034426) Prothrombin time (PT)

151

1.26

0.38

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

170

0.76

0.38

1.2

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

225

0.80

0.37

1.1

1.6

2.24

4.56

ug/l

—

172

(3028300) Cannabinoids [Presence] in Urine

876

1.10

0.37

1.7

—

(4146454) Self-monitoring of blood glucose

524

1.13

0.37

3.4

2.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.35

0.37

1.6

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

216

1.20

0.36

4.5

3.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

226

1.20

0.35

1.7

1.5

—

(40768441) Liver Pathology biopsy report

347

1.15

0.35

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.64

0.35

1.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

853

1.09

0.34

1.6

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

542

0.88

0.34

1.4

1.5

1509.78

2095.10

e6/l

0.57

407

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

274

1.17

0.33

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.33

0.33

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

145

1.24

0.33

1.7

1.5

48.22

131.31

nmol/24h

1.19

145

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

118

1.27

0.33

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

1.27

0.33

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.30

0.33

1.0

—

(3036489) Thrombin time

176

1659

1.06

0.32

1.9

2.0

21.33

21.49

0.16

152

1450

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.28

0.32

1.2

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

146

1.23

0.32

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

137

1.24

0.32

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

327

0.86

0.31

1.6

1.5

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.31

0.31

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

1.29

0.31

1.0

1.2

—

(3024928) Oxygen saturation in Venous blood

916

1.08

0.31

3.3

3.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

249

1.17

0.30

1.9

1.7

3.67

1.99

u/field

0.69

170

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

240

1.17

0.30

2.3

2.2

95.60

264.72

ug/min

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.29

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

228

0.83

0.29

1.8

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.23

0.29

7.7

5.8

36.71

47.72

ug/min

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

115

1075

1.07

0.28

1.4

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

195

0.82

0.28

1.1

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

204

1.18

0.28

4.6

3.1

34.10

27.88

mu/l

0.26

197

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

167

1.20

0.28

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

397

0.88

0.28

2.5

2.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

317

1.14

0.28

6.9

6.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

129

0.77

0.28

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

517

1.10

0.28

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.29

0.28

1.4

1.7

—

(40761536) Microorganisms panel - Urine sediment

373

3859

0.96

0.27

4.7

4.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.25

0.27

3.4

2.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

150

1.20

0.26

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.69

0.26

1.0

1.3

21.50

46.40

mg/l

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

299

0.87

0.26

1.1

—

(3010421) pH of Blood

129

1217

1.06

0.25

3.6

4.1

7.42

0.07

122

1104

(3027456) Digoxin [Moles/volume] in Serum or Plasma

103

965

1.07

0.25

2.8

3.2

0.78

0.83

nmol/l

0.57

735

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

477

0.90

0.25

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

675

1.08

0.25

1.4

1.2

3.57

3.36

u/ml

0.04

211

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

226

1.15

0.24

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

226

1.15

0.24

1.2

1.6

—

(3020491) Glucose [Moles/volume] in Blood

321

1.12

0.24

1.5

2.1

6.95

6.86

mmol/l

0.03

209

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.17

0.24

3.1

2.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

244

0.86

0.24

1.3

1.4

130.87

204.41

pmol/l

1.04

244

(3047352) Trisomy 18 risk [Likelihood] in Fetus

318

0.88

0.24

1.5

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

218

1.15

0.23

1.4

2.2

—

(3000991) Gas panel - Venous blood

384

3731

1.03

0.22

7.4

8.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

825

1.07

0.22

1.6

1.4

—

(3005033) Fetal Nuchal fold Thickness US

316

0.89

0.22

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

276

1.12

0.22

3.2

3.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

545

0.92

0.22

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.22

0.22

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.19

0.21

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

2.28

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

230

2385

0.96

0.21

9.2

9.1

24.23

24.36

mmol/l

0.23

213

2317

(3035320) C reactive protein [Mass/volume] in Body fluid

315

1.11

0.21

2.7

2.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

58.86

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

730

1.07

0.21

1.6

1.4

113.08

118.33

u/ml

0.22

144

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.16

0.21

1.0

1.1

—

9.97

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

117

1.20

0.20

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.25

0.20

1.5

1.1

—

(3003181) Sodium [Moles/volume] in Urine

858

1.06

0.20

1.3

64.97

62.24

mmol/l

0.25

690

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

136

1.18

0.20

2.4

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

1.18

0.20

2.3

3.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

1.18

0.20

2.3

3.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.18

0.19

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

385

0.91

0.19

1.2

—

(3016879) Cocaine [Presence] in Urine

802

1.06

0.19

1.7

1.8

—

(3003129) Base excess in Capillary blood by calculation

118

1.19

0.19

1.6

1.9

-0.42

1.48

mmol/l

1.12

111

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

453

1.08

0.18

2.5

2.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

161

1547

1.04

0.18

2.0

1.7

6.49

3.96

mg/l

1.15

131

1164

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

223

1.12

0.18

6.2

4.8

2964.83

56.31

u/ml

—

(3045142) Bone marrow Pathology biopsy report

551

1.07

0.18

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.17

0.17

4.0

3.1

—

28.79

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

142

0.84

0.17

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.13

0.17

1.6

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

599

0.93

0.17

1.4

1.5

34.99

32.24

g/l

0.80

543

(3032057) Clostridioides difficile [Presence] in Stool

110

1.18

0.17

1.9

2.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

349

1.09

0.17

1.1

1.0

312.69

336.81

ng/l

0.23

238

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.75

0.17

2.0

1.2

—

(3024263) Appearance of Synovial fluid

253

1.11

0.16

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

546

0.93

0.16

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

225

1.11

0.16

8.2

11.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.21

0.15

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.21

0.15

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.15

0.15

1.0

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

121

1.16

0.15

1.1

1.3

185.86

129.94

nmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

1.11

0.15

6.1

6.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

891

0.95

0.14

2.9

3.0

—

(3015183) Erythrocyte sedimentation rate

188

1.12

0.14

2.6

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

352

1.08

0.14

1.1

1.0

923.74

710.75

ng/l

1.76

232

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

183

1775

1.03

0.14

3.4

3.3

593.42

3386.88

u/ml

1.04

150

1506

(3008536) Aspergillus sp Ab [Presence] in Serum

1.18

0.14

1.5

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.18

0.14

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

405

3974

1.02

0.14

6.3

6.7

1.42

1.33

mmol/l

0.72

394

3886

(3006653) Thiamine [Moles/volume] in Blood

227

1.10

0.14

1.2

147.12

134.69

nmol/l

0.56

227

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

496

4878

1.02

0.14

3.4

—

(40768806) Pleura Pathology biopsy report

459

0.94

0.13

1.5

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

117

0.85

0.13

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

134

1297

1.03

0.12

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

355

1.07

0.12

1.1

1.0

40.42

45.46

ng/l

0.32

237

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

258

1.09

0.12

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.18

0.12

1.5

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

457

0.94

0.12

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.16

0.11

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1189

11792

1.01

0.11

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

124

1.13

0.11

1.1

227.78

308.20

pmol/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

153

1.11

0.11

1.4

59.50

63.55

0.14

129

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

377

1.06

0.10

2.5

2.1

3.53

2.11

u/field

0.41

151

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

0.89

0.10

1.8

2.0

2081.88

20478.78

e6/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

362

0.94

0.10

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

125

1.12

0.10

1.2

1.1

—

(3024471) HLA-A [Type]

125

1.12

0.10

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

437

1.05

0.10

2.6

2.8

69.24

27.19

mg/l

0.62

310

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.11

0.09

1.0

—

(1002224) Polysomnography panel

170

1662

1.02

0.09

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

664

1.04

0.09

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

674

1.04

0.09

1.5

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

340

1.06

0.09

2.1

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.04

0.09

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

635

1.04

0.09

1.1

79.59

77.45

iu/ml

0.01

140

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

165

1.09

0.08

2.6

2.3

371.67

843.35

e6/l

1.46

117

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.05

0.08

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

302

1.06

0.08

1.3

1.2

—

(3018133) Calcium [Moles/volume] in Urine

1.03

0.08

1.0

1.8

1.53

2.84

mmol/l

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.79

0.08

1.6

4.0

—

(3014891) Appearance of Pleural fluid

0.78

0.08

1.8

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

117

1.11

0.08

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.09

0.08

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

0.83

0.07

1.0

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.82

0.07

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.85

0.07

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.83

0.07

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

118

1.10

0.07

4.5

5.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

167

1.08

0.06

1.6

1.4

—

1472393.75

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.09

0.06

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

234

0.94

0.06

3.8

3.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

110

1077

1.02

0.06

2.7

3.4

766.25

660.67

u/ml

0.06

103

974

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

0.91

0.06

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

0.92

0.05

1.4

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

129

1.09

0.05

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

141

0.92

0.05

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

435

0.97

0.05

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

743

1.02

0.05

1.2

35.51

39.87

u/l

0.11

643

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

150

0.93

0.04

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

453

0.97

0.04

1.4

1.5

0.23

0.29

nmol/l

0.51

331

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

666

1.02

0.04

1.4

1.2

2.24

4.28

u/ml

2.62

268

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

206

2080

0.99

0.04

3.3

4.0

23.83

24.31

mmol/l

1.74

201

2037

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

637

1.02

0.03

1.2

1.1

118.00

118.25

0.02

562

(3035880) pH of Pleural fluid

250

1.04

0.03

1.5

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

531

5292

1.00

0.02

3.3

4.0

32.96

23.37

ug/l

0.17

410

4314

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

108

1.02

0.00

1.1

1.3

—

(3036180) Methadone [Presence] in Urine

118

1.02

0.00

4.2

1.4

—

(3048879) Bone marrow aspiration report

138

1.01

0.00

1.4

1.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

192

0.99

0.00

10.3

11.8

0.54

0.63

mmol/l

1.14

178

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

218

1.01

0.00

2.6

2.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

155

0.97

0.00

1.2

—

0.31

g/l

—

(3011648) Oxygen content in Venous blood

348

1.01

0.00

2.0

11.95

11.01

0.88

348

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

265

0.98

0.00

1.2

1.3

1.63

1.61

g/l

0.12

265

(4035726) Immunohistochemistry procedure

444

4442

1.00

0.00

1.4

—

(3044007) Cell count panel - Peritoneal fluid

134

0.97

0.00

3.1

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

183

0.98

0.00

1.4

2.3

35.14

138.25

umol/l

—

107

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

217

1.01

0.00

1.1

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.01

0.00

1.3

1.7

—

(3024932) HLA-DR beta [Type]

121

0.99

0.00

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

249

1.00

0.00

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

6.4

—

64.43

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

17.80

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.94

-0.00

3.2

2.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.4

—

2854.43

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

110

1.00

-0.00

1.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.8

—

6.80

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(4212803) Bone marrow aspirate examination

0.96

-0.00

1.0

1.1

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

240

1.00

-0.00

1.2

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.86

-0.00

2.4

3.8

24.40

42.59

umol/l

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.00

-0.00

3.2

2.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.3

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

1.20

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.02

-0.00

2.2

1.6

35.20

42.94

umol/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

0.99

-0.00

1.1

—

5.09

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

2.4

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_LICHENPLANUS – Lichen planus

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lichen planus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Lichen planus (L12_LICHENPLANUS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints